import{_ as h}from"./TableOfContents.bdd6f6dd.js";import{_ as k}from"./client-only.ac4e2e02.js";import g from"./Icon.b194f7c3.js";import{_ as v}from"./ContentImage.173c53fe.js";import{_ as f,o as r,c as p,b as e,w as t,a,d as s,h as i,f as M,g as b,i as m}from"./entry.98172cbe.js";import"./useUserPreferences.5d49139f.js";import"./config.2e15eb2e.js";const _={},C={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},S={class:"e-article",lang:"et",style:{hyphens:"auto"}},A=i('<h1 class="mb-0">Kanep ja “imerohud”</h1><h5 class="font-normal uppercase leading-tight">Teaduslik taustainfo</h5><section id="s1"><h2 id="s1t">Sissejuhatus</h2><p class="mt-20"> Moodul keskendub peamiselt kanepile ning sellest toodetud narkootikumitele. Alternatiivne tegevusliin, mida selles moodulis uurida, on skandaalne aine nimega MMS (Miracle Mineral Solution), mis on kloordioksiidi vesilahuse kaubamärgi nimetus, mida ühtlasi kasutatakse tööstusliku pleegitusainena, mida aga on ekslikult reklaamitud mitmete haiguste, sealhulgas HIV-i, vähi, COVID-19, külmetushaiguste aga ka autismi ravimina. </p><p> Allpoololevast tekstist leiab selgitused järgmistele probleemidele / väidetele / müütidele. </p><h4><a href="#s2">Mis on kanep?</a></h4><ul class="leading-tight"><li class="my-0"><a href="#myth-1">Müüt nr 1: Kanep ei ole tervisele eriti ohtlik</a></li><li class="my-0"><a href="#myth2">Müüt nr 2: Mõnele noorele kanep sobib</a></li><li class="my-0"><a href="#myth-3">Müüt nr 3. Kanep on meditsiinis kasutatav ravim ja seetõttu kõigile ohutu</a></li><li class="my-0"><a href="#myth-4">Müüt nr 4: Marihuaana parandab meeleolu ja edendab vaimset tervist</a></li><li class="my-0"><a href="#myth5">Müüt nr 5: Kanep ei tekita sõltuvust</a></li><li class="my-0"><a href="#myth-6">Müüt nr 6: Kanep on väravaks kangematele narkootikumidele</a></li><li class="my-0"><a href="#myth-7">Müüt nr 7: Kanepiga ei saa üledoosi</a></li><li class="my-0"><a href="#myth-8">Müüt nr 8: Kanepisuits on ohutu</a></li></ul><h4><a href="#s3">Mis on MMS?</a></h4><ul class="leading-tight"><li class="my-0"><a href="#safety">Ohutus</a></li><li class="my-0"><a href="#miracle-drug">MMS-i kui “imeravimi” turundamine</a></li><li class="my-0"><a href="#myth-9">MMS ja valeväited COVID-19 ravi kohta</a></li><li class="my-0"><a href="#myth-10">MMS ja valeväited tema muude ravivõimete kohta</a></li><li class="my-0"><a href="#myth-11">Müüt nr 11: MMS aitab langetada kehakaalu</a></li></ul></section>',3),x={id:"s2"},D=i('<h2 id="s2t">Mis on kanep?</h2><p> Kanep (või marihuaana) viitab kolmest psühhoaktiivsete omadustega taimest koosnevale rühmale: <i>Cannabis sativa</i>, <i>Cannabis indica</i> ning <i>Cannabis ruderalis</i>. Kui nende taimede õied korjata ja kuivatada, on tulemuseks üks maailma levinumaid narkootikume. Kanep koosneb enam kui 120 ainest, mida tuntakse kannabinoididena. Kaks kõige tuntumat kannabinoidi on kannabidiool (CBD) ja delta-9-tetrahüdrokannabinool (THC). CBD on kanepis leiduv keemiline ühend, leviku poolest teisel kohal ning on viimasel ajal muutunud alternatiivse ravivahendina populaarseks mitmete haigusseisundite korral. Seda võib saada kanepist <sup><span class="tooltip" data-tip="Termin “kanep” tähendab kanepit, mille THC sisaldus on 0,3 protsenti või vähem kuivkaalust">[1]</span></sup>. THC on kanepi peamine psühhoaktiivne koostisosa, THC aktiveerib aju tasustamissüsteemi, andes ajule märku keemilise signaali - dopamiini vabastamiseks <a href="https://nida.nih.gov/publications/research-reports/marijuana/how-does-marijuana-produce-its-effects" target="_blank" rel="noopener noreferrer"><sup>[2]</sup></a>. </p>',2),T=a("b",null,"Joonis 1.",-1),I=a("p",null,[s(" Ilmselt ei tekita ükski teine taim nii palju arutelusid ja väärarusaamu kui kanep. Selle kasutamine ja populaarsus läbi aegade on viinud selleni, et mõned on seda tembeldanud superravimiks, teised aga häbimärgistavad kui “kurja juurt”, pluss paljud teised vaatenurgad nende kahe vahel. Viimasel kümnendil on uimastite legaliseerimine mitmetes riikides lõõgastumise eesmärgil ja levitatav teave selle kasulikkuse kohta suurendanud väärarusaamu veelgi enam. Eestis kasutamise kohta vt. siit "),a("a",{href:"https://drive.google.com/file/d/1gX2od53KWaygwney13ijwXzu0wc3mK9W/view?usp=share_link",target:"_blank",rel:"noopener noreferrer",class:"tooltip","data-tip":"Veterinaar- ja Toiduamet. (2019). Kanepi ekstraktid ja kannabidiool (CBD)."},[a("sup",null,"[3]")]),s(" . Tarvitamisega seotud riskide kohta on saadaval palju infot, aga samuti samuti selle tarvitamisega seotud kasude kohta. Sageli esitatakse info ilma korralike viideteta. Järgnevalt vaatame, mida on teadlastel ja meditsiinitöötajatel öelda enamlevinud kanepitarvitamisega seotud müütide kohta, viidates seejuures vastavatele teadusuuringutele. ")],-1),N=a("p",null,[s(" More information about the health effects of cannabis can be found from: "),a("a",{class:"break-all",href:"https://docs.google.com/document/d/1kxisOjHc0qINFXhWvmdmMAJyjp7V9JmgfWXDhCKeuyk/edit",target:"_blank",rel:"noopener noreferrer"},"https://docs.google.com/document/d/1kxisOjHc0qINFXhWvmdmMAJyjp7V9JmgfWXDhCKeuyk/edit")],-1),H={id:"s3"},q=i('<h2 id="s3t">Müüdid kanepi kohta</h2><h3 id="myth-1"><span class="text-rose-400">Müüt nr 1:</span> Kanep ei ole tervisele eriti ohtlik </h3><p> On väidetud, et kanep ei ole tervisele ohtlik, vaid isegi kasulik. See müüt on laialt levinud, kuna mitmes riigis on levinud arusaam, et teised uimastid on palju mürgisemad ning kanep on kasutusel ravieesmärkidel alternatiivse ravimina. </p><p> Teaduslike tõendite kohaselt on kanepit seostatud suure hulga tervisemõjudega (Joonis 2). Kõige olulisemad tagajärjed hõlmavad vaimuhaigusi <sup><span class="tooltip" data-tip="Paruk S &amp; Burns JK. 2016. Kanep ja vaimuhaigused noorukitel: ülevaade. Lõuna-Aafrika perepraktika, 58:sup1, S18-S21.">[4]</span></sup>, südame-veresoonkonna haigusi <sup><span class="tooltip" data-tip="Thomas G et al. 2014. Marihuaana sissehingamise kahjulikud kardiovaskulaarsed, tserebrovaskulaarsed ja perifeersed vaskulaarsed mõjud: Mida kardioloogid peavad teadma. American Journal of Cardiology 113 (1): 187-190.">[5]</span></sup>, kopsuhaigusi <sup><span class="tooltip" data-tip="Joshi M et al. 2014. Marihuaana ja kopsuhaigused. Current Opinios of Pulmonary Medicine 20(2):173-179.">[6]</span></sup> ning hingamisteede ja munandivähki <sup><span class="tooltip" data-tip="Riiklikud Teaduste, Inseneriteaduste ja Meditsiini Akadeemiad. 2017. Kanepi ja kannabinoidide mõju tervisele: tõendite praegune seis ja soovitused uuringuteks. Washington, DC: National Academies Press.">[7]</span></sup>. Mõned riskirühmad, nagu teismelised ja rasedad naised, on kanepitarbimise suhtes eriti haavatavad. Samuti on oluline mõista passiivse suitsetamisega seotud ohtusid, kuna kanepisuits (ka passiivne) on füüsikaliste ja keemiliste omaduste poolest väga sarnane tubakasuitsuga <sup><span class="tooltip" data-tip="Graves BM et al. 2020. Peavoolu marihuaana ja tubakasuitsu põhjalik iseloomustus. Scientific Reports 10(1):7160.">[8]</span></sup>. Veelgi enam, kanepitarbimine on seotud sõltuvusega, see suurendab teiste uimastite tarvitamise riski ning on teatatud ka üledoosidest. </p>',4),P=a("b",null,"Joonis 2.",-1),E=i('<h3 id="myth-2"><span class="text-rose-400">Müüt nr 2:</span> Mõnele noorele kanep sobib </h3><p> Kuna paljud noored kasutavad kanepit, on kasvanud veendumus, et selle kasutamine on okei. Uuringute kohaselt võib kanepitarbimine, eriti noorukieas ja varases täiskasvanueas, kahjustada õppimise ja mäluga seotud ajuosa <a href="http://venturacountylimits.org.s94613.gridserver.com//resources/ article/E413A9/marijuana-and-your-kids-brain-video" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Ventura maakond. 2015. Marihuaana ja teie lapse aju. Marihuaana Ventura maakonnas: värav aruteluks, Ventura maakonna käitumistervis."></a>. Mõned uuringud näitavad, et regulaarne marihuaana kasutamine noorukieas on seotud aju muutunud närviühenduste ja aju teatud piirkondade mahu vähenemisega, mis on seotud täidesaatvate funktsioonidega, nagu mälu, õppimine ja impulsside juhtimine <sup><span class="tooltip" data-tip="Batalla A et al. 2013. Krooniliste kanepitarbijate struktuursed ja funktsionaalsed pildiuuringud: süstemaatiline ülevaade noorukite ja täiskasvanute leidudest. PloS One 8(2): e55821.">[10]</span></sup>. Kõige olulisem on see, et uuringute kohaselt võib regulaarne kanepitarbimine noorukieas kaasa tuua koolis kehvema hakkamasaamise ja suurema koolist väljalangemise <sup><span class="tooltip" data-tip="Fergusson, DM et al. 2010. Kanep ja haridusalased saavutused: kolme Austraalia kohordiuuringu tulemused. Narko- ja alkoholisõltuvus, 110, 3.">[11]</span></sup>. On näidatud, et noorukite ja noorte täiskasvanute kanepitarbimisest põhjustatud aju struktuursed muutused on püsivad – IQ tulemused vähenevad ja neid ei saa vanusekasvades taastada <sup><span class="tooltip" data-tip="Meier MH et al. 2012. Püsivad kanepitarvitajad näitavad neuropsühholoogilist allakäiku lapsepõlvest keskeani. Ameerika Ühendriikide riikliku teaduste akadeemia toimetised, 109:E2657-2664">[12]</span></sup>. </p><h3 id="myth-3"><span class="text-rose-400">Müüt nr 3.</span> Kanep on meditsiinis kasutatav ravim ja seetõttu kõigile ohutu </h3><p> Praegu on kanepile või kanepist saadud toodetele olemas kolm tunnustatud kasutusviisi: seda määratakse keemiaraviga seotud iivelduse ja oksendamise vastu, HIV / AIDSi levikuga seotud isutuse vastu ja paari haruldase lapseea epilepsia tüübi korral <sup><span class="tooltip" data-tip="National Academies of Sciences, Engineering and Medicine, 2017. Kanepi ja kannabinoidide terapeutiline toime. sisseKanepi ja kannabinoidide mõju tervisele: tõendite praegune seis ja soovitused uuringuteks. National Academies Press (USA)">[13]</span></sup>. Kõigi muude haiguste, sealhulgas psühhiaatriliste seisundite korral, ei ole kanep laialdaselt heaks kiidetud. Varasemate andmete põhjal võivad kannabinoiditeraapiad (sisaldavad peamiselt CBD-d) pakkuda sobivamat ravi ärevushäirega inimestele või võimaliku abistava toimena ärevuse või stressiga seotud häirete ravis <sup><span class="tooltip" data-tip="Sharpe L et al. 2020. Kanep, ärevuse põhjus? Anksiogeensete ja anksiolüütiliste omaduste kriitiline hinnang. Journal of Translational Medicine, 18:374.">[14]</span></sup>. Teatud uuringud on siiski näidanud, et see võib ise tekitada ärevust, paanikat, paranoiat ja psühhoosi. </p><p> Kui kanep on tervendavatel eesmärkidel heaks kiidetud, on suure tõenäosusega tegemist spetsiifilise tootega, milles on fikseeritud kontsentratsioon spetsiifilisi kannabinoide nagu kannabidiool (CBD) ja delta-9-tetrahüdrokannabinool (THC) (Joonis 3). Lisaks on arutatud CBD/THC suhte olulisuse üle. On leitud, et ravimkanepis mängib see suhe otsustavat rolli ajuvähiga patsientide füüsilise ja funktsionaalse heaolu parandamisel <sup><span class="tooltip" data-tip="Schloss J et al. 2021. 2. faasi randomiseeritud kliiniline uuring, milles hinnatakse kahe erineva ravikanepi vahekorra talutavust kõrge astme glioomiga patsientidel. Frontiers in Oncology, 11:649555.">[15]</span></sup>. Ainult kontrollitud (meditsiini)toodetes saab CBD ja THC kontsentratsiooni ja annuseid kontrollida. </p>',5),B=a("b",null,"Joonis 3.",-1),K=i('<h3 id="myth-4"><span class="text-rose-400">Müüt nr 4:</span> Marihuaana parandab meeleolu ja edendab vaimset tervist </h3><p> On hästi teada, et kanepis sisalduv TBC tekitab narkojoobe. See võib panna inimest tundma õnnelikuna, lõdvestunult, jutukamana või naerma rohkem kui tavaliselt. Võib juhtuda, et värvid ja muusika on heledamad ja teravamad. Täpne mõju meeleolule on inimeseti väga erinev, kuid üldiselt on emotsioonid liialdatud sarnaselt alkoholi joobeseisundiga <sup><span class="tooltip" data-tip="Gruber SA et al., 2009. Muutunud afektiivne reaktsioon marihuaana suitsetajatel: FMRI uuring. Drug and Alcohol Dependence, 105(1-2), 139-153.">[16]</span></sup>. </p><p> Need &quot;positiivsed&quot; mõjud ilmnevad aga lühiajaliselt, samas kui pikaajaline kasutamine on seotud suure hulga negatiivsete mõjudega vaimsele tervisele. Nagu alkohol, on ka marihuaana ja sellega seotud THC-d sisaldavad tooted joovastavad ained ning võivad aidata kaasa otsustusvõime halvenemisele ja suurenenud vastuvõtlikkusele vaimse tervise probleemidele, sealhulgas depressioon, unetus ja paranoilised luulud <a href="http://www2.nami.org/Content/NavigationMenu/Hearts_and_ Minds/Smoking_Cessation/Marijuana_and_Mental_Illness.htm" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="National Alliance on Mental Illness (2013) Marihuaana ja vaimuhaiguste teabeleht. Duckworth, K., Freedman, J., arvustajad."><sup>[17]</sup></a>. Psühhootiliste häiretega inimestel on märkimisväärne oht sümptomite ägenemiseks või süvenemiseks <sup><span class="tooltip" data-tip="D’Souza DR. 2015. Meditsiiniline marihuaana: kas vanker on enne hobust? Journal of the American Medical Association, 313(24), 2431-2432">[18]</span></sup>. Regulaarne marihuaana tarbimine on seotud ärevuse, depressiooni ja psühhootiliste haigustega inimeste suurenenud riski ja/või sümptomite halvenemisega <sup><span class="tooltip" data-tip=" Hill, K. 2015. Meditsiiniline marihuaana kroonilise valu ja muude meditsiiniliste ja psühhiaatriliste probleemide raviks: kliiniline ülevaade. Journal of the American Medical Association, 313(24), 2474-2483">[19]</span></sup>. On tõendeid, mis näitavad seost tugeva kanepi kasutamise ja psühhootiliste haiguste, sealhulgas skisofreenia vahel, kuid tõendeid on endiselt vähe ja mehhanisme ei mõisteta täielikult <sup><span class="tooltip" data-tip=" Patel S. 2020. Seos kanepitarbimise ja skisofreenia vahel: põhjus või ravi? Süstemaatiline ülevaade. Cureus Journal of Medical Science, 12(7), e9309.">[20]</span></sup>. </p><h3 id="myth-5"><span class="text-rose-400">Müüt nr 5:</span> Kanep ei tekita sõltuvust </h3><p> Müüt põhineb tõsiasjal, et kõigist marihuaanat kasutavatest inimestest vastab mingil eluperioodil sõltuvuse kriteeriumidele vaid umbes 9%. Kui aga vaadata inimesi, kes hakkavad marihuaanat tarvitama noorukieas (kui aju alles areneb ja on üsna haavatav), siis on neil neli kuni seitse korda suurem tõenäosus jääda kanepisõltuvusse kui täiskasvanutel <sup><span class="tooltip" data-tip=" Winters KC ja Lee C-YS. 2008. Alkoholi- ja kanepitarbimise häire tekkimise tõenäosus nooruses: seos hiljutise tarbimise ja vanusega. Drug and Alcohol Dependence, 92(1-3), 239-247">[21]</span></sup>. Värskeimad andmed viitavad sellele, et 30%-l regulaarselt kanepit tarvitajatest võib esineda sõltuvushäireid <sup><span class="tooltip" data-tip="Hasin DS et al. 2015. Marihuaana tarvitamise häirete levimus Ameerika Ühendriikides aastatel 2001-2002 ja 2012-2013. JAMA Psychiatry, 72(12), 1235-1242">[22]</span></sup>. </p><p> Samuti on näidatud, et tänapäevased THC tüved on tugevamad – ja tekitavad füsioloogilist sõltuvust ja võõrutusnähtusi <sup><span class="tooltip" data-tip=" Copeland J, Swift W. 2009. Kanepitarbimise häire: epidemioloogia ja juhtimine. International Review of Psychiatry, 21(2), 96-103">[23]</span></sup>, mis nõuavad juba spetsiaalset võõrustusravi. Kui kroonilised kanepitarbijad üritavad ravi järsult katkestada, on võõrutussündroomi nähud – rahutus, ärrituvus, hüperaktiivsus, unetus, iiveldus, krambid, söögiisu vähenemine, higistamine ja sagenenud unenäod, sagedased <sup><span class="tooltip" data-tip="Bonnet U &amp; Preuss UW. 2017. Kanepi võõrutussündroom: praegused arusaamad. Ainete kuritarvitamine ja rehabilitatsioon, 8, 9-37">[24]</span></sup>. </p><h3 id="myth-6"><span class="text-rose-400">Müüt nr 6:</span> Kanep on väravaks kangematele narkootikumidele </h3><p> Siinkohal on teaduslikud tõendid ebamäärased ja põhjuslikku seost ei ole otseselt kinnitatud, kuid kui vaadata kõiki teisi narkootikume tarvitavaid inimesi, siis enamik neist on alustanud kanepist. Sellegi poolest ei tähenda see, et kui keegi tarvitab kanepit, siis hakkab ta tingimata kasutama kangemaid narkootikume, nagu kokaiin. Kuid teatud protsent kanepitarbijatest teeb seda. Kui võrrelda kanepitarbimist muu uimastitarbimisega, siis enamikus riikides on kanep palju levinum <a href=" https://www.emcdda.europa.eu/data/stats2021/gps_en" target="_blank" rel="noopener noreferrer"><sup>[25]</sup></a>. Kuid ainuüksi levimuse põhjal ei saa me luua seoseid pikaajalise kasutamise ja väravaks olemise hüpoteesiga. </p><p> 25 aastat kestnud longituuduuring on leidnud, et marihuaana tarvitamise sagedus on märkimisväärne teiste ebaseaduslike kuritarvitamise ja sõltuvust tekitavate uimastite seas – eriti noorukieas <sup><span class="tooltip" data-tip=" Fergusson DM et al. 2006. Kanepitarbimine ja muu ebaseaduslik uimastitarbimine: kanepivärava hüpoteesi testimine. Sõltuvus, 101(4), 556-569">[26]</span></sup>. Kahes eraldi uuringus kaksikutega on võrreldud, kas kanepi varajane tarvitamine näitab hilisemat kuritarvitamist või sõltuvust teistest ebaseaduslikest uimastitest. Leiud näitasid kaks kuni viis korda suuremat riski kui kaksikul, kes ei kasutanud marihuaanat <sup><span class="tooltip" data-tip=" Lynskey MT et al. 2003. Narkootikumide tarvitamise eskaleerumine varajase algusega kanepitarbijatel vs kaas-kaksikute kontrollid. JAMA, 289(4), 427-433.">[27]</span></sup><sup><span class="tooltip" data-tip=" Agrawal A et al. 2004. Kanep ja muud ebaseaduslikud uimastid: kaasnev tarbimine ja kuritarvitamine/sõltuvus meestel ja naistel. Behavior Genetics, 34(3), 217-228.">[28]</span></sup>. </p><p> Teine seletus muu narkotarbimise “väravaks” olemise ja sõltuvuse kohta põhineb aju neurobioloogial – vähenenud tasutundlikkus ja suurenenud ootustundlikkus võtavad üle aju juhtimisahela <sup><span class="tooltip" data-tip="Volkow ND et al. 2010. Sõltuvus: vähenenud tundlikkus tasu eest ja suurenenud ootustundlikkus võivad aju juhtimisahela üle koormata. Bioesseys, 32(9), 748-755.">[29]</span></sup>. Teisisõnu, mäluahela ajamid tasuvad meie ootusi ja suurendavad motivatsiooni uimastit tarbida. Kokkuvõtteks: tõendid on vastuolulised, kuid seos näib olevat paljude kanepitarbijate lõikes olemas. </p><h3 id="myth-7"><span class="text-rose-400">Müüt nr 7:</span> Kanepiga ei saa üledoosi </h3><p> Otseselt kanepitarbimisse surra ei saa, aga on võimalus üleannustada, mis toob kaasa füüsilised kannatused (iiveldus, oksendamine), äärmise ärevuse, paranoia ja lühiajalise psühhoosi (kaob kontakt reaalsuse). Nende mõjude kadumiseks võib kuluda mitu tundi. Kanepi üledoosi ei saada just väga sageli, kuid risk on olemas, kui tarbitakse mitteametlikke kanepitooteid. See võib juhtuda, kuna tavaliselt ei saa tarvitaja oma annust ja kannabinoidide sisaldust täpselt mõõta. Kuna kanepitarvitamine on enamikus riikides palju suurem kui teiste uimastite tarbimine, on kanepi kõrvaltoimed toonud kaasa palju rohkem kiirabi külastusi kui teiste narkootikumide puhul <a href=" https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/DAWN2k11ED.pdf" target="_blank" rel="noopener noreferrer"><sup>[30]</sup></a>. </p><p> Üleannustamise tagajärjeks võib olla ka psühhiaatrilise seisundi halvenemine, eriti psühhoos: see väljendub paranoias, asjade nägemises, kuulmises, luululise mõtlemises. Kanepis sisalduv kannabinoid - THC võib seda halvendada. Mõnikord antakse neile inimestele antipsühhootilisi ravimeid, et sümptomeid leevendada ja neid ennast mugavamalt tundma panna. Teine asi, mille pärast inimesed kiirabisse võivad sattuda, on kanepi hüperemeedi sündroom (CHS) <a href="https://my.clevelandclinic.org/health/diseases/21665-cannabis-hyperemesis-syndrome" target="_blank" rel="noopener noreferrer"><sup>[31]</sup></a>. CHS on seisund, mis on põhjustatud pikaajalisest kanepitarbimisest. Inimesed, kellel on CHS, kogevad korduvaid iivelduse, oksendamise, dehüdratsiooni ja kõhuvalu episoode, külastades sageli erakorralise meditsiini osakonda. </p><p> Lõõgastumise eesmärgil tarbitud kanepi ägedat toksilisust on uuritud ka USA-s Alaskal <sup><span class="tooltip" data-tip="Noble MJ et al. 2019. Äge kanepi mürgisus. Clinical Toxicology, 57(8), 735-742.">[32]</span></sup>. Neurotoksilisus on tavaline pärast ägedat kokkupuudet kanepiga. Lapsed kogesid tahtmatut kokkupuudet, eriti kodus, ja mõnikord ka tõsiste kahjulike tagajärgedega. Kontsentreeritud tooteid, nagu vaigud ja vedelad kontsentraadid, seostati teiste kanepitoodetega võrreldes suurema mürgisusega. Teine teaduskirjanduses käsitletav aspekt on meditsiinilise kanepi mõju opioidide (manustatud näiteks valu vaigistamiseks vähihaigetel) üleannustamisele ja suremusele. Samas on tõendid segased <sup><span class="tooltip" data-tip="Shover CL et al. 2019. Seos meditsiinilise kanepi seaduste ja opioidide üleannustamise suremuse vahel on aja jooksul pöördunud. Proceedings of the National Academy of Sciences of the United States, 116(26), 12624-12626.">[33]</span></sup>. </p><p> Kokkuvõtteks näib seos kehtivat (esineb korrelatsioon), kuid põhjuslik seos pole selge. </p><h3 id="myth-8"><span class="text-rose-400">Müüt nr 8:</span> Kanepisuits on ohutu </h3><p> Nagu mis tahes muu passiivse suitsu puhul, võivad lapsed kanepi passiivses suitsus sisalduvaid mürgiseid aineid ja kantserogeene kergesti sisse hingata. Selles on palju samu kemikaale, mis tubakasuitsus <sup><span class="tooltip" data-tip="Graves B.M. et al. 2020. Peavoolu marihuaana ja tubakasuitsu põhjalik iseloomustus. Scientific Reports 10(1):7160.">[34]</span></sup>, sealhulgas need, mis on seotud kopsuvähiga. </p><p> Kasutatud marihuaanasuits sisaldab ka THC-d, ühendit, mis vastutab enamiku kanepi psühhoaktiivsete mõjude eest. See võib levida imikutele ja lastele passiivse suitsetamise kaudu ning passiivse kanepisuitsuga kokkupuutuvad inimesed võivad kogeda psühhoaktiivseid mõjusid, näiteks kõrgendatud enesetunnet <sup><span class="tooltip" data-tip="Wilson KM et al. 2017. Kasutatud marihuaanasuitsu biomarkerite tuvastamine väikelastel. Pediatric Research, 81(4), 589-592.">[35]</span></sup>. Hiljutised uuringud on leidnud tugeva seose teadete vahel, et kodus on keegi, kes kasutab marihuaanat (nt vanem, sugulane või hooldaja) ning lapsel tuvastatav THC taseme vahel <sup><span class="tooltip" data-tip="Moore C et al. 2011. Kannabinoidid suuvedelikus pärast passiivset kokkupuudet marihuaanasuitsuga. Forensic Science International, 212(1-3), 227-230.">[36]</span></sup>. On näidatud, et imikutel, kes puutuvad kokku passiivse marihuaanasuitsuga, on oht imikute äkksurma sündroomi (teise nimega SIDS) esinemisele <sup><span class="tooltip" data-tip="Reece-Stremtan S &amp; Marinelli KA. 2015. ABM-i kliiniline protokoll nr 21: imetamise ja ainete kasutamise või ainete kasutamise häire juhised, läbivaadatud 2015. Breastfeeding Medicine, 10(3), 135-141.">[37]</span></sup>. </p><p> Neid fakte arvesse võttes põhjustab kanepisuits selgelt terviseriske. Sageli aga järeldavad mitmed veebilehed, et see tõenäoliselt ei mõjuta inimesi, kes puutuvad sellega kokku hästi ventileeritavas keskkonnas. Teaduslike faktide põhjal ei vasta see tõele, eriti siseruumide puhul. </p><h3> Muud usaldusväärsed allikad </h3><p><a class="break-all" href="https://www.unodc.org/documents/drug-prevention-and-treatment/cannabis_review.pdf " target="_blank" rel="noopener noreferrer">https://www.unodc.org/documents/drug-prevention-and-treatment/cannabis_review.pdf</a></p>',21),O=i('<hr><section id="s3"><h2 id="s3t"> Mis on MMS? </h2><p> Miracle Mineral Solution, ka Master Mineral Solution (MMS) on kloordioksiidi (ClO2) vesilahuse kaubamärgi kohta esinevad nimetused; sisuliselt on tegemist tööstusliku valgendiga, mida arvatakse ekslikult ravivat selliseid haigusi nagu HIV, vähk ja külmetus <a href="https://en.wikipedia.org/w/index.php?title=Miracle_Mineral_Supplement&amp;oldid=1130854435" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Wikipedia kaastöölised. (2022). Miracle mineraalne toidulisand."><sup>[38]</sup></a> <a href="https://www.terviseamet.ee/et/uudised/mms-kloordioksiidil-pohinev-tervisele-kahjulik-lahus" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Eesti Ravimiamet. (2018). MMS on kloordioksiidil põhinev tervisele kahjulik lahus."><sup>[39]</sup></a>. Selle nimetuse mõtles välja endine saientoloog Jim Humble oma 2006. aastal ilmunud raamatus &quot;The Miracle Mineral Solution of the 21st Century&quot; <a href="https://uk.news.yahoo.com/parents-making-children-drink-bleach-160057178.html" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Newsweek/Yahoo News. (28. jaanuar 2018). Vanemad panevad oma lapsi jooma valgendit, et neid autismist ravida."><sup>[40]</sup></a>. Humble väidab, et lahus võib ravida HIV-i, malaariat, hepatiidi viirust, gripiviirust H1N1, külmetushaigusi, autismi, aknet, vähki ja muid haigusi. Nende väidete tõestuseks puuduvad kliinilised uuringud <a href="https://www.terviseamet.ee/et/uudised/mms-kloordioksiidil-pohinev-tervisele-kahjulik-lahus" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Estonian Drug Administration (Eesti Ravimiamet). (20. juulil2018).MMS on kloordioksiidil põhinev tervisele kahjulik lahus."><sup>[41]</sup></a> <a href="https://www.fda.gov/consumers/consumer-updates/danger-dont-drink-miracle-mineral-solution-or-similar-products" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="USA Toidu- ja Ravimiamet. (8. detsember 2019).Oht: ärge jooge Miracle’i mineraallahust ega sarnaseid tooteid."><sup>[42]</sup></a>, need pärinevad ainult üksikjuhtumite kirjeldustest ja Humble&#39;i raamatust <a href="https://en.wikipedia.org/w/index.php?title=Miracle_Mineral_Supplement&amp;oldid=1130854435" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Wikipedia kaastöölised. (2022).Miracle mineraalne toidulisand. Vikipeedia, vaba entsüklopeedia."><sup>[43]</sup></a>. Vaatamata puuduvatele teaduslikele tõenditele on MMS-i propageerinud erinevad inimesed ja organisatsioonid üle maailma. </p><p> MMS valmistatakse naatriumkloriti (NaClO₂) vesilahuse segamisel happega (N: soolhape, tsitrusviljamahl, äädikas): </p><h4 class="mt-0" style="font-variant-numeric:lining-nums;"><span class="break-keep whitespace-nowrap">5NaCl0₂ + 4HCl</span> → <span class="break-keep whitespace-nowrap">5NaCl + 4ClO₂ + 2H₂O</span></h4><p> Selle tulemusena tekib kloordioksiid, mürgine kemikaal, mis võib põhjustada iiveldust, oksendamist, kõhulahtisust ja dehüdratsioonist tingitud eluohtlikult madalat vererõhku <a href="https://web.archive.org/web/20190814102219/https://www.fda.gov/news-events/press-announcements/fda-warns-consumers-about-dangerous-and-potentially-life-threating-side-effects-miracle-mineral" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Toidu- ja Ravimiamet (2019).FDA hoiatab tarbijaid Miracle Mineral Solutioni ohtlike ja potentsiaalselt eluohtlike kõrvalmõjude eest .fda.gov."><sup>[44]</sup></a>. Naatriumklorit on kloordioksiidi peamine lähteaine ja on mürgine allaneelamisel <a href="https://web.archive.org/web/20070710214037/http://www.emea.europa.eu/pdfs/vet/mrls/sodiumchlorite.pdf" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Euroopa Ravimiamet. (2007). Naatriumkloriit – Euroopa Ravimihindamisameti kokkuvõtlik aruanne – Veterinaarravimite hindamisüksus (PDF)."><sup>[45]</sup></a>. Suured annused võivad põhjustada ägedat neerupuudulikkust. Väikesed annused (ligikaudu 1 gramm) võivad põhjustada iiveldust, oksendamist, soolepõletikku ja olla isegi eluohtlikud glükoos-6-fosfaatdehüdrogenaasi puudulikkusega patsientidel <a href="https://doi.org/10.3109%2F08860229309069417" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip=" Lin J.L. &amp; Lim, P.S. (1993). Neerupuudulikkusega seotud äge naatriumkloriti mürgistus.Ren Fail.15(5): 645–8.doi:10.3109/08860229309069417.PMID 8290712."><sup>[46]</sup></a>. </p><p> Kloordioksiidi on kasutatud ka joogivee desinfitseerimisvahendina <sup><span class="tooltip" data-tip="Block, Seymour Stanton (2001). Desinfitseerimine, steriliseerimine ja säilitamine (5. väljaanne). Lippincott, Williams ja Wilkins. lk. 215. ISBN 0-683-30740-1.">[47]</span></sup>. Euroopa Komisjoni direktiiv <a href="https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A31998L0083" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="NÕUKOGU DIREKTIIV 98/83/EÜ, 3. november 1998, olmevee kvaliteedi kohta"><sup>[48]</sup></a> kehtestab kloordioksiidi maksimaalseks lubatud kontsentratsiooniks joogivees mitte rohkem kui 0,2 miljondikosa (ppm), samas kui USA Keskkonnakaitseagentuur (EPA) on määranud selleks 0,8 (ppm) <a href="https://wwwn.cdc.gov/TSP/ToxFAQs/ToxFAQsDetails.aspx?faqid=581&amp;toxid=108" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Toksiliste ainete ja haiguste registri agentuur – ToxFAQs™: kloordioksiid ja kloriit. www.atsdr.cdc.gov."><sup>[49]</sup></a>. </p><h3 id="safety"> Ohutus </h3><p> Meditsiiniline nõuanne on, et igaüks, kellel on see toode, peaks selle kasutamise kohe lõpetama ja minema viskama <a href="https://www.terviseamet.ee/et/uudised/mms-kloordioksiidil-pohinev-tervisele-kahjulik-lahus" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Estonian Drug Administration (Eesti Ravimiamet). (20. juulil 2018). MMS on kloordioksiidil põhinev tervisele kahjulik lahus."><sup>[50]</sup></a> <a href="https://www.fda.gov/consumers/consumer-updates/danger-dont-drink-miracle-mineral-solution-or-similar-products" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="USA Toidu- ja Ravimiamet. (8. detsember 2019). Oht: ärge jooge Miracle’i mineraallahust ega sarnaseid tooteid."><sup>[51]</sup></a>. Riiklikud agentuurid paljudes riikides <a href="http://www.food.gov.uk/news-updates/news/2012/jul/cdswarning#.UJ8EzIawUzQ" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Ühendkuningriik Toidustandardite amet. (3. juuli 2012). Agentuuri hoiatus kloorilahuste kohta"><sup>[52]</sup></a> <a href="https://web.archive.org/web/20120520125838/http://food.gov.uk/news/newsarchive/2010/sep/mms" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Toidustandardite Agentuur. (2012). Hoiatus Miracle Mineral Solutioni tarbimise eest"><sup>[53]</sup></a>, on hoiatanud MMS-i mõjude eest: &quot;MMS on 28% naatriumkloriti lahus, mis on samaväärne tööstusliku tugevusega pleegitusainega. Kui seda kasutatakse vastavalt juhistele, võib see põhjustada tugevat iiveldust, oksendamist ja kõhulahtisus, mis võib põhjustada dehüdratsiooni ja alandada vererõhku. Kui lahust lahjendatakse ettenähtust vähem, võib see kahjustada soolestikku ja punaseid vereliblesid, mis võib põhjustada hingamispuudulikkust.&quot; Ka lahjemad versioonid võivad kahjustada, kuigi see on vähem tõenäoline. Müüjad seostavad oksendamist, iiveldust ja kõhulahtisust toote ravitoimega, kuid tegelikult on selle põhjuseks toote mürgisus <a href="https://web.archive.org/web/20130606115516/http://moh.gov.ms/?p=803" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Montserrat: tervishoiuministeerium. (6. juuni 2013) Toote hoiatus: Miracle Mineral Solution."><sup>[54]</sup></a>. </p><p> MMS-i ei ole heaks kiidetud ühegi haiguse raviks ja krooniline kokkupuude kloordioksiidi väikeste annustega võib põhjustada reproduktiiv- ja neuroarengukahjustusi <a href="https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0648_summary.pdf" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Kloriit (naatriumisool) (CASRN 7758-19-2) | IRIS | USA EPA (PDF). Epa.gov. Ameerika Ühendriikide Keskkonnakaitseagentuur."><sup>[55]</sup></a>. </p><h3 id="miracle-drug"> MMS-i kui “imeravimi” turundamine </h3><p> Turundajate valeväidete kohaselt ravib imelahuse tilkade manustamine kiiresti paljud või kõik haigused ja vaevused, sealhulgas vähk, AIDS, gripp, autism jne. Turunduses on põhiliseks meetodiks võrkturundus ja avalikkusele suletud kogukonnad sotsiaalvõrgustikes. Tarbijale suunatud kommunikatsioon hõlmab sõnavara, mis seostub tervislike eluviisidega (mõisted &quot;öko&quot; jms), kasutab ära haavatavate tarbijate teadmatust ja meeleheidet ning sageli ka vastumeelsust tavameditsiini vastu <a href="https://et.wikipedia.org/wiki/MMS" target="_blank" rel="noopener noreferrer"><sup>[56]</sup></a>. </p><h3 id="myth-9"><span class="text-rose-400">Myth No 9:</span> MMS ja valeväited COVID-19 ravi kohta </h3><p> Kuigi väitel, et MMS võib ravida COVID-19 või mõnda muud haigust, pole teaduslikku alust <a href="https://www.mysuncoast.com/2020/07/08/federal-agencies-hazmat-crews-respond-bradenton-church-selling-covid-miracle-solution/" target="_blank" rel="noopener noreferrer"><sup>[57]</sup></a><a href="https://www.thedailybeast.com/qanon-conspiracy-theorists-magic-cure-for-coronavirus-is-drinking-lethal-bleach" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Sommer, Will (28. jaanuar 2020). QAnon-ersi maagiline ravim koroonaviiruse vastu: jooge lihtsalt valgendit!. Daily Beast. Arhiveeritud originaalist 10. veebruaril 2020."><sup>[58]</sup></a><a href="https://www.youtube.com/watch?v=QEZpb4an8eM" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Halperin, Dan (30. jaanuar 2020). QAnoni YouTube&#39;i kasutajad käsivad inimestel koroonaviiruse tõrjumiseks juua valgendit. Youtube. Veerev kivi."><sup>[59]</sup></a> , siis COVID-19 pandeemia ajal hakkasid paljud varasemad MMS-i propageerijad, nagu QAnoni toetaja Jordan Sather ja USA Genesis II Tervise ja Tervendamise kirik, propageerima seda kui COVID-19 ravimit. Nt. 2019. aasta suve alguses korraldas Genesis II Tervise ja Tervendamise Kirik MMS-i levitamiseks seminare Tšiilis, Ecuadoris, Lõuna-Aafrikas ja Uus-Meremaal <a href="https://www.theguardian.com/us-news/2019/aug/16/bleach-based-miracle-cure-group-seminar-new-york" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Pilkington, Ed (2019-08-16). Rühm, kes tutvustab New Yorgi osariigi seminaril valgendipõhist imeravimit. Eestkostja. Vaadatud 2019-08-16."><sup>[60]</sup></a> . 2020. aastal sai USA Florida lõunapiirkonna advokaadibüroo ettekirjutuse kiriku teise haru vastu, kes turustas MMS-i spetsiaalselt COVID-19 ravivahendina, kasutades anonüümseid edulugusid ja viidates vandenõuteooriatele <a href="https://www.cbsnews.com/news/florida-church-coronavirus-bleaching-agent-cure-covid-19/" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Quinn, Melissa; Siduma, siduma; Hymes, Clare (17. aprill 2020), Feds otsib Florida kirikut, kes müüb COVID-19 raviks pleegitusainet, CBS uudised."><sup>[61]</sup></a> . Kohus andis korralduse sulgeda kõik MMS-i müüvad veebisaidid, takistada kirikul uute veebisaitide loomist ja konfiskeerida kõik MMS-i tegemiseks kasutatud materjalid. Samuti tehti kirikule ülesandeks teavitada kliente, et toote levitamine on olnud ebaseaduslik <a href="https://web.archive.org/web/20160415120703/http://www.ethicalagents.co.nz/ProductPDF/Tristel-Trio-Wipe-System.pdf" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Triseli salvrätikute süsteemi tooteteave (PDF). Eetilised agendid. Arhiveeritud alatesoriginaal (PDF) 15. aprillil 2016."><sup>[62]</sup></a> . </p><p> Boliivias propageerisid Cochabamba ametnikud MMS-i kui ravi COVID-19 vastu ja kongress võttis vastu seaduseelnõu, millega lubatakse &quot;kloordioksiidi lahuse tootmine, turustamine, tarnimine ja kasutamine koroonaviiruse ennetamiseks ja raviks&quot;. Selle tagajärjel sai mürgituse vähemalt 15 inimest <a href="https://www.theguardian.com/world/2020/jul/17/bolivia-coronavirus-toxic-bleach-chlorine-dioxide" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Cochabamba, Associated Press (17. juuli 2020). Meeleheitel boliivlased otsivad mürgist pleegitajat, mida on ekslikult reklaamitud kui Covid-19 ravi. Eestkostja. Välja vaadatud 2. veebruaril 2021."><sup>[63]</sup></a>. </p><h3 id="myth-10"><span class="text-rose-400">Myth No 10:</span> MMS ja valeväited tema muude ravivõimete kohta </h3><p> ABC uudised ja KABC-TV USA-s uurisid 2016. aastal MMS-i fenomeni ja avastasid Lõuna-California ümber koondunud &quot;maa-aluse võrgustiku&quot;, mis propageerib MMS-i haiguste, sealhulgas vähi, Parkinsoni tõve ja laste autismi raviks <a href="https://tervis.postimees.ee/6853276/need-on-2019-aasta-koige-ohtlikumad-tervisemuudid" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Vanemad panevad oma lapsi jooma valgendit, et neid autismist ravida. Newsweek/Yahoo News. 28. jaanuar 2018."><sup>[64]</sup></a>. </p><p> Nii tegi ka nt. Kerri Rivera (USA), kes andis lapsevanematele põhjendamatuid ja ebaprofessionaalseid meditsiinilisi ja tervisealaseid nõuandeid MMS-i kasutamiseks autismi ja muude tõsiste haiguste &quot;ravimiseks&quot;. Hiljem esitati talle kriminaalsüüdistus. Rivera haldas aga Facebooki lehte ja veebisaiti, mis propageerisid ohtlikku MMS-klistiiri kui autismiravi ja väitis, et laste soolestiku koetükid on tegelikult parasiidid (&quot;paelussid&quot;) <a href="https://en.wikipedia.org/wiki/Intestinal_epithelium" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Köie ussid (või köieussid) on pseudoteaduslik termin pikkade õhukeste kahjustatud tükkide kohtasoole epiteel või muu soolesisaldus, mis on valesti tuvastatud kui inimese parasiit-ussid."><sup>[65]</sup></a>, mis oli ilmselgelt vale <a href="https://www.autism.com/statement_mms" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Hoiatus kloordioksiidi kasutamise eest. Autismi uurimisinstituut. Vaadatud 24. septembril 2016."><sup>[66]</sup></a>. </p><h3 id="myth-11"> Müüt No 11: MMS aitab langetada kehakaalu </h3><p> Eesti erinevates sotsiaalmeedia portaalides on hakanud viimastel aastatel levitama info MMS-ist kui tõhusast kaalulangetajast. Sellelele on aidanud hoogsalt kaasa ka näiteks portaal telegram.ee (Vt näiteks: <a href="https://www.telegram.ee/toit-ja-tervis/mms-ravib-vahki-ja-teised-edulood-eestist" target="_blank" rel="noopener noreferrer">https://www.telegram.ee/toit-ja-tervis/mms-ravib-vahki-ja-teised-edulood-eestist</a>) </p><p> Kui kellelgi üldse peaks pähe tulema taoline mõte, siis tasuks eelkõige meenutada MMS-i tarvitamise kõrvaltoimeid, mis isegi vastavalt juhistele tarvitades, võivad põhjustada tugevat iiveldust, oksendamist ja kõhulahtisus, mis omakorda võib põhjustada dehüdratsiooni ja alandada vererõhku. Veidi kangemal kujul võib see kahjustada aga juba soolestikku ja punaseid vereliblesid ning põhjustada hingamispuudulikkust. Krooniline kokkupuude kloordioksiidi väikeste annustega võib põhjustada reproduktiiv- ja neuroarengukahjustusi <a href="https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0648_summary.pdf" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Chlorite (sodium salt)(CASRN 7758-19-2) | IRIS | USA EPA (PDF).Epa.gov. U.S. Environmental Protection Agency. National Center for Environmental Assessment"><sup>[67]</sup></a>. Seega pole ime, kui MMS-i üheks kõrvaltoimeks on ka kaalulangus, sest toit ei jää lihtsalt organismi püsima. Toitainete ja mineraalide puudus organismis oksendamise ning kõhulahtisuse ning hullemal juhul soolestiku kahjustumise tagajärjel on liiga kõrge hind võimalikule (kuigi vastavad uuringud puuduvad) kaalulangusele. </p><h3> Rohkem viiteid MMS-i ja selle tervisemõjude kajastuse kohta: </h3><ul><li><a href="https://tervis.postimees.ee/6853276/need-on-2019-aasta-koige-ohtlikumad-tervisemuudid" target="_blank" rel="noopener noreferrer">https://tervis.postimees.ee/6853276/need-on-2019-aasta-koige-ohtlikumad-tervisemuudid</a></li><li><a href="https://ekspress.delfi.ee/artikkel/120051408/eksperiment-huva-nou-mms-i-grupist-jata-koer-janusse-kull-ta-mmsiga-segatud-vett-lopuks-jooma-hakkab" target="_blank" rel="noopener noreferrer">https://ekspress.delfi.ee/artikkel/120051408/eksperiment-huva-nou-mms-i-grupist-jata-koer-janusse-kull-ta-mmsiga-segatud-vett-lopuks-jooma-hakkab</a></li><li><a href="https://www.delfi.ee/artikkel/93002771/fotod-viljandi-bussipeatustes-reklaamitakse-koroonaviiruse-raviks-mms-i" target="_blank" rel="noopener noreferrer">https://www.delfi.ee/artikkel/93002771/fotod-viljandi-bussipeatustes-reklaamitakse-koroonaviiruse-raviks-mms-i</a></li></ul></section>',2);function J(c,u){const l=h,d=k,o=g,n=v;return r(),p("div",C,[e(d,null,{default:t(()=>[e(l,{class:"w-full lg:max-w-xs print:hidden",key:"drugs-bg-en"})]),_:1}),a("section",S,[e(o,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),A,a("section",x,[D,e(n,{src:"https://evidence.onkel.ee/assets/drugs__cannabis.webp",credits:"Pixabay: https://pixabay.com/photos/marijuana-herbal-cannabis-hemp-5858148/",elevated:!0},{caption:t(()=>[T,s(" Kanepitaimed ")]),_:1}),I,N]),a("section",H,[q,e(n,{elevated:"",src:"https://evidence.onkel.ee/assets/drugs__cannabis-medical-effects.webp"},{caption:t(()=>[P,s(" Kanepi mõju tervisele. ")]),_:1}),E,e(n,{elevated:"",src:"https://evidence.onkel.ee/assets/drugs__cannabis-products.webp"},{caption:t(()=>[B,s(" Kanep ja tooted, mis sisaldavad teatud kontsentratsioonis kannabinoide. ")]),_:1}),K]),O])])}const F=f(_,[["render",J]]),V={},R={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},W={class:"e-article",lang:"el",style:{hyphens:"auto"}},U=i('<h1 class="mb-0">Ναρκωτικά</h1><h5 class="font-normal uppercase leading-tight">Επιστημονικό Περιεχόμενο</h5><section id="s-1"><h2 id="s-1t">Introduction</h2><p class="mt-20"> Η Ενότητα «Ναρκωτικές Ουσίες» επικεντρώνεται στην κάνναβη. </p><p> Στην παρούσα ενότητα παρουσιάζονται οι πιο κάτω μύθοι: </p><h4><a href="#s2">Τι είναι η κάνναβη;</a></h4><ul class="leading-tight"><li class="my-0"><a href="#myth-1">Μύθος 1: Η κάνναβη δεν είναι επικίνδυνη για την υγεία.</a></li><li class="my-0"><a href="#myth2">Μύθος 2: Η χρήση της κάνναβης είναι κατάλληλη από μερικούς νέους.</a></li><li class="my-0"><a href="#myth-3">Μύθος 3. Η κάνναβη αποτελεί ένα ναρκωτικό που χρησιμεύει στην ιατρική.</a></li><li class="my-0"><a href="#myth-4">Μύθος 4: Η κάνναβη βοηθά στην αύξηση της ανθρώπινης διάθεσης και προωθεί τη ψυχική υγεία.</a></li><li class="my-0"><a href="#myth5">Μύθος 5: Η κάνναβη δεν είναι εθιστική.</a></li><li class="my-0"><a href="#myth-6">Μύθος 6: Η κάνναβη είναι ένα ναρκωτικό που σε βοηθάει να ξεφύγεις από την πραγματικότητα.</a></li><li class="my-0"><a href="#myth-7">Μύθος 7: Δεν μπορεί κάποιος να κάνει υπερβολική χρήση κάνναβης.</a></li><li class="my-0"><a href="#myth-8">Μύθος 8: Ο παθητικός δέκτης του καπνού της κάνναβης είναι ασφαλής.</a></li></ul></section>',3),$={id:"s2"},z=i('<h2 id="s2t">What is cannabis?</h2><p><span class="e-term">H Κάνναβη</span> (ή Μαριχουάνα) αναφέρεται σε μία ομάδα τριών φυτών με ψυχοδραστικές ιδιότητες, γνωστά ως <i>Cannabis sativa</i>, <i>Cannabis indica</i>, και <i>Cannabis ruderalis</i>. Όταν τα άνθη αυτών των φυτών συλλεχθούν και αποξηρανθούν, αποτελούν ένα από τα πιο κοινά ναρκωτικά στον κόσμο. Η κάνναβη αποτελείται από πάνω από 120 συστατικά τα οποία είναι γνωστά ως κανναβινοειδή. Τα δύο πιο γνωστά κανναβινοειδή είναι η κανναβιδιόλη (CBD) και η δέλτα-9- τετραϋδροκανναβινόλη (THC). H CBD είναι η δεύτερη πιο διαδεδομένη χημική ένωση που βρίσκεται στην κάνναβη και πρόσφατα έχει γίνει πιο δημοφιλής ως εναλλακτική θεραπεία για πολλές παθήσεις. Μπορεί να προέρχεται από σπόρους <sup><span class="tooltip" data-tip="The term “hemp” is used to mean cannabis that contains 0.3 percent or less THC content by dry weight">[1]</span></sup> κάνναβης ή από τα άνθη της κάνναβης. Η THC είναι το κύριο ψυχοδραστικό συστατικό της κάνναβης που ενεργοποιεί το σύστημα ανταμοιβής του εγκεφάλου σηματοδοτώντας την απελευθέρωση της χημικής ντοπαμίνης <a href="https://nida.nih.gov/publications/research-reports/marijuana/how-does-marijuana-produce-its-effects" target="_blank" rel="noopener noreferrer"><sup>[2]</sup></a> του εγκεφάλου. </p>',2),L=a("b",null,"Σχήμα 1.",-1),G=a("p",null," Κανένα άλλο φυτό δεν προκαλεί τόση συζήτηση και λανθασμένες αντιλήψεις όπως η κάνναβη. Η χρήση και η δημοτικότητα του ανά τους αιώνες οδήγησε στο να χαρακτηρίζεται από κάποιους ως ένα «σούπερ» φάρμακο, και από άλλους να στιγματίζεται ως «κακό» για την κοινωνία. ",-1),Q=a("p",null," Την τελευταία δεκαετία μάλιστα, η νομιμοποίηση της κάνναβης για ψυχαγωγική χρήση σε πολλές χώρες, καθώς επίσης οι ευρέως διαθέσιμες πληροφορίες για τα οφέλη που έχει οδήγησαν στην αύξηση των λανθασμένων αντιλήψεων που σχηματίζει ο κόσμος για αυτό. ",-1),Y=a("p",null," Πληροφορίες υπάρχουν πολλές όσον αφορά τους κινδύνους που προκαλεί η χρήση της κάνναβης όπως υπάρχουν και πολλές που αφορούν τα οφέλη της. Οι περισσότερες πληροφορίες βέβαια υπάρχουν στο διαδίκτυο χωρίς να δίδονται οι ανάλογες αναφορές και αποδείξεις για αυτές. ",-1),X=a("p",null," Ακολούθως, θα δούμε τι έχουν να πουν οι επιστήμονες και η ιατρική κοινότητα σχετικά με τους περισσότερους μύθους που επικρατούν σχετικά με τη χρήση της κάνναβης/μαριχουάνας κάνοντας αναφορά σε επιστημονικές μελέτες. ",-1),Z={id:"s3"},aa=i('<h2 id="s3t">Myths about drugs</h2><h3 id="myth-1"><span class="text-rose-400">Μύθος 1:</span> Η κάνναβη δεν είναι επικίνδυνη για την υγεία </h3><p> Αρκετοί υποστηρίζουν ότι η κάνναβη δεν είναι τόσο επικίνδυνη για την υγεία, αντιθέτως είναι και ωφέλιμη. Αυτός ο μύθος είναι ευρέως διαδεδομένος με αρκετές απόψεις να ισχυρίζονται το γεγονός ότι άλλα ναρκωτικά είναι πολύ πιο τοξικά από τη χρήση της κάνναβης η οποία αξιοποιείται για θεραπευτικούς σκοπούς ως εναλλακτικό φάρμακο σε αρκετές χώρες. Ωστόσο, σύμφωνα με επιστημονικά στοιχεία, η κάνναβη έχει συσχετιστεί με μεγάλο αριθμό επιπτώσεων στην υγεία (Σχήμα 2). Οι πιο σημαντικές επιπτώσεις περιλαμβάνουν ψυχικές ασθένειες <sup><span class="tooltip" data-tip="Paruk S &amp; Burns JK. 2016. Cannabis and mental illness in adolescents: a review. South African Family Practice, 58:sup1, S18-S21.">[3]</span></sup>, καρδιαγγειακές παθήσεις <sup><span class="tooltip" data-tip="Thomas G et al. 2014. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. American Journal of Cardiology 113(1):187-190.">[4]</span></sup>, ασθένειες των πνευμόνων <sup><span class="tooltip" data-tip=" Joshi M et al. 2014. Marijuana and lung diseases. Current Opinions of Pulmonary Medicine 20(2):173-179.">[5]</span></sup> και καρκίνο <sup><span class="tooltip" data-tip="Joshi M et al. 2014. Marijuana and lung diseases. Current Opinions of Pulmonary Medicine 20(2):173-179. ">[6]</span></sup>του αναπνευστικού και των όρχεων. </p><p> Ορισμένες ομάδες κινδύνου όπως οι έφηβοι και οι εγκυμονούσες είναι ιδιαίτερα ευάλωτες στη χρήση κάνναβης. Επίσης, το παθητικό κάπνισμα είναι ζωτικής σημασίας καθώς ο παθητικός καπνός της κάνναβης μοιάζει πολύ με τον καπνό του τσιγάρου από άποψη φυσικών και χημικών ιδιοτήτων <sup><span class="tooltip" data-tip="Graves BM et al. 2020. Comprehensive characterization of mainstream marijuana and tobacco smoke. Scientific Reports 10(1):7160.">[7]</span></sup>. Ακόμη, η χρήση της κάνναβης σχετίζεται με τον εθισμό, αυξάνει τον κίνδυνο χρήσης άλλων ναρκωτικών και αρκετοί κάνουν χρήση κάνναβης σε υπερβολική δόση. </p>',4),ea=a("b",null,"Σχήμα 2.",-1),sa=i('<h3 id="myth-2"><span class="text-rose-400">Μύθος 2:</span> Η χρήση της κάνναβης είναι κατάλληλη από μερικούς νέους. </h3><p> Καθώς αρκετοί νέοι χρησιμοποιούν κάνναβη, υπάρχει αυξημένη πεποίθηση ότι είναι εντάξει να χρησιμοποιείται από αυτούς. Ωστόσο, σύμφωνα με μελέτες, η χρήση κάνναβης ειδικά κατά την εφηβεία και την πρώιμη ενήλικη ζωή, μπορεί να βλάψει το τμήμα του εγκεφάλου που σχετίζεται με τη μνήμη <sup><span class="tooltip" data-tip="Ventura County. 2015. Marijuana and Your Kid’s Brain.” Marijuana in Ventura County: A Gateway for Discussion, Ventura County Behavioral Health. http:// venturacountylimits.org.s94613.gridserver.com//resources/ article/E413A9/marijuana-and-your-kids-brain-video.">[8]</span></sup> και τη μάθηση. </p><p> Άλλες μελέτες υποδεικνύουν ότι η τακτική χρήση μαριχουάνας στην εφηβεία σχετίζεται με αλλοιωμένη συνδεσιμότητα και μειωμένο όγκο συγκεκριμένων περιοχών του εγκεφάλου που εμπλέκονται σε ένα ευρύ φάσμα εκτελεστικών λειτουργιών όπως η μνήμη, η μάθηση και ο έλεγχος των παρορμήσεων σε σύγκριση με άτομα που δεν χρησιμοποιούν <sup><span class="tooltip" data-tip="Batalla A et al. 2013. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PloS One 8(2):e55821.">[9]</span></sup>. </p><p> Η πιο σημαντική διαπίστωση σύμφωνα με μελέτες είναι ότι η τακτική χρήση κάνναβης κατά την εφηβεία μπορεί να οδηγήσει σε χαμηλότερες σχολικές επιδόσεις και υψηλότερα ποσοστά <sup><span class="tooltip" data-tip="Fergusson, DM et al. 2010. Cannabis and Educational Achievement: Findings from Three Australian Cohort Studies. Drug and Alcohol Dependence, 110, 3.">[10]</span></sup> εγκατάλειψης του σχολείου. Έχει αποδειχθεί μάλιστα ότι οι δομικές αλλαγές που προκαλούνται στον εγκέφαλο από τη χρήση κάνναβης στους εφήβους και στους νεαρούς ενήλικες είναι μόνιμες – το επίπεδο του IQ χαμηλώνει και δεν μπορεί να ανακτηθεί με την ηλικία <sup><span class="tooltip" data-tip="Meier MH et al. 2012. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences of the United States of America, 109:E2657-2664">[11]</span></sup>. </p><h3 id="myth-3"><span class="text-rose-400">Μύθος 3:</span> Η κάνναβη αποτελεί ένα ναρκωτικό φάρμακο που χρησιμεύει στην ιατρική. </h3><p> Μέχρι σήμερα υπάρχουν τρεις αναγνωρισμένες χρήσεις της κάνναβης ή των προϊόντων που προέρχονται από κάνναβη: για αντιμετώπιση της ναυτίας και του εμετού που είναι βασικές επιπτώσεις χημειοθεραπείας, για αντιμετώπιση της ανορεξίας που σχετίζεται με προχωρημένο HIV/AIDS, και για την αντιμετώπιση σπάνιων μορφών παιδικής επιληψίας <sup><span class="tooltip" data-tip="National Academies of Sciences, Engineering, and Medicine, 2017. Therapeutic effects of cannabis and cannabinoids. In The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. National Academies Press (US)">[12]</span></sup>. Όλες οι άλλες χρήσεις, συμπεριλαμβανομένων των ψυχιατρικών παθήσεων δεν είναι ευρέως εγκεκριμένες. Με βάση πρόσφατα δεδομένα, οι θεραπείες με κανναβινοειδή (που περιέχουν κυρίως CBD) μπορεί να παρέχουν μία πιο κατάλληλη θεραπεία για άτομα που έχουν άγχος ή ως συμπληρωματική θεραπεία στη διαχείριση του άγχους ή διαταραχών <sup><span class="tooltip" data-tip="Sharpe L et al. 2020. Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. Journal of Translational Medicine, 18:374.">[13]</span></sup> που σχετίζονται με το άγχος και το στρες. Ωστόσο, ορισμένες έρευνες έχουν δείξει ότι μπορεί η ίδια η χρήση της κάνναβης να προκαλέσει συναισθήματα άγχους, πανικού, παράνοια και ψύχωση. </p><p> Για να έχει εγκριθεί η κάνναβη για θεραπευτικούς σκοπούς, πιθανότατα θα πρόκειται μόνο για ένα συγκεκριμένο προϊόν κάναβης με σταθερές συγκεντρώσεις συγκεκριμένων κανναβινοειδών(CBD) όπως είναι η κανναβιδιόλη και η δέλτα-9-τετραϋδροκανναβινόλη (THC) (Σχήμα 3). </p><p> Επιπλέον, έχει συζητηθεί ότι η αναλογία CBD/THC έχει σημασία. Συγκεκριμένα, στη φαρμακευτική κάνναβη έχει αποδειχθεί ότι η αναλογία παίζει καθοριστικό ρόλο στη βελτίωση της σωματικής και λειτουργικής ευεξίας των ασθενών με καρκίνο του εγκεφάλου <sup><span class="tooltip" data-tip="Schloss J et al. 2021. A phase 2 randomised clinical trial assessing the tolerability of two different ratios of medicinal cannabis in patients with high grade gliomas. Frontiers in Oncology, 11:649555.">[14]</span></sup>. Μόνο σε ελεγχόμενα (ιατρικά) προϊόντα η συγκέντρωση και οι δόσεις CBD και THC μπορούν να ελεγχθούν. </p>',8),ia=a("b",null,"Σχήμα 3.",-1),na=i('<h3 id="myth-4"><span class="text-rose-400">Μύθος 4:</span> Η κάνναβη βοηθά στην αύξηση της ανθρώπινης διάθεσης και προωθεί τη ψυχική υγεία. </h3><p> Είναι γνωστό ότι η ουσία TBC που εμπεριέχει η κάνναβη προκαλεί ένα αίσθημα έξαρσης κατά το οποίο το άτομο αισθάνεται χαρούμενο, χαλαρό, είναι περισσότερο ομιλητικό και γελάει περισσότερο από το συνηθισμένο. Επιπλέον διαπιστώνει ότι τα χρώματα τριγύρω είναι πιο φωτεινά και η μουσική πιο έντονη από την πραγματικότητα. Οι ακριβείς επιπτώσεις της χρήσης της κάνναβης ποικίλουν από άτομο σε άτομο, ωστόσο σε γενικές γραμμές μοιάζουν αρκετά με τον τρόπο επίδρασης του αλκοόλ <sup><span class="tooltip" data-tip="Gruber SA et al., 2009. Altered affective response in marijuana smokers: An FMRI study. Drug and Alcohol Dependence, 105(1-2), 139-153.">[15]</span></sup> στον ανθρώπινο οργανισμό. </p><p> Τα πιο πάνω συναισθήματα εμφανίζονται από τη βραχυπρόθεσμη χρήση της κάνναβης, ενώ η μακροχρόνια χρήση της κάνναβης σχετίζεται με υψηλό αριθμό αρνητικών επιπτώσεων στη ψυχική υγεία. Για παράδειγμα, το αλκοόλ, η μαριχουάνα και τα σχετικά προϊόντα που περιέχουν THC είναι μεθυστικά και μπορούν να συμβάλουν σε μειωμένη κρίση και αυξημένη ευαισθησία σε προβλήματα ψυχικής υγείας, όπως κατάθλιψη, αϋπνία και παρανοϊκές παραληρητικές ιδέες <sup><a class="tooltip" data-tip="National Alliance on Mental Illness (2013) Marijuana and Mental Illness Fact Sheet. Duckworth, K., Freedman, J., reviewers." href="http://www2.nami.org/Content/NavigationMenu/Hearts_and_ Minds/Smoking_Cessation/Marijuana_and_Mental_Illness.htm" target="_blank" rel="noopener noreferrer">[16]</a></sup>. </p><p> Επιπλέον, υπάρχει σημαντικός κίνδυνος υποτροπής ή επιδείνωσης των συμπτωμάτων για άτομα με ψυχωτικές διαταραχές <sup><span class="tooltip" data-tip="D’Souza DR. 2015. Medical marijuana: Is the cart before the horse? Journal of the American Medical Association, 313(24), 2431-2432.">[17]</span></sup>. Η τακτική χρήση μαριχουάνας συσχετίζεται με αυξημένο κίνδυνο και/ή επιδείνωση των συμπτωμάτων για άτομα με άγχος, κατάθλιψη και ψυχωτικές ασθένειες <sup><span class="tooltip" data-tip="Hill, K. 2015. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. Journal of the American Medical Association, 313(24), 2474-2483.">[18]</span></sup>. Υπάρχουν ορισμένα στοιχεία που δείχνουν συσχέτιση μεταξύ της χρήσης της κάνναβης και των ψυχωτικών ασθενειών, συμπεριλαμβανομένης της σχιζοφρένειας. Ωστόσο, τα επιστημονικά στοιχεία εξακολουθούν να είναι ελάχιστα και οι μηχανισμοί δεν είναι πλήρως κατανοητοί <sup><span class="tooltip" data-tip="Patel S. 2020. The association between cannabis use and schizophrenia: causative or curative? A systematic review. Cureus Journal of Medical Science, 12(7), e9309.">[19]</span></sup>. </p><h3 id="myth-5"><span class="text-rose-400">Μύθος 5:</span> Η κάνναβη δεν είναι εθιστική. </h3><p> Ο μύθος βασίζεται στο γεγονός ότι από όλους τους ανθρώπους που κάνουν χρήση μαριχουάνας, μόνο το 9% περίπου θα πληροί τα κριτήρια για εθισμό σε κάποια στιγμή της ζωής τους αργότερα. Ωστόσο, αν εξετάσουμε τους ανθρώπους που αρχίζουν χρήση μαριχουάνας από εφηβική ηλικία, όταν δηλαδή ο εγκέφαλός τους εξακολουθεί να αναπτύσσεται και είναι ακόμη ευάλωτος, τότε έχουν τέσσερις έως επτά φορές περισσότερες πιθανότητες να αναπτύξουν μία διαταραχή από τη χρήση κάνναβης σε σύγκριση με έναν ενήλικα <sup><span class="tooltip" data-tip="Winters KC &amp; Lee C-YS. 2008. Likelihood of developing an alcohol and cannabis use disorder during youth: Association with recent use and age. Drug and Alcohol Dependence, 92(1-3), 239-247.">[20]</span></sup>. </p><p> Πρόσφατα δεδομένα υποδηλώνουν ότι το 30% όσων κάνουν χρήση κάνναβης τακτικά μπορεί να εμφανίσουν σε κάποιο βαθμό διαταραχή από τη χρήση <sup><span class="tooltip" data-tip="Hasin DS, et al. 2015. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry, 72(12), 1235-1242.">[21]</span></sup>. </p><p> Έχει επίσης αποδειχθεί ότι τα σημερινά στελέχη THC είναι ισχυρότερα – και τώρα προκαλούν φυσιολογική εξάρτηση και απόσυρση που απαιτεί θεραπεία κατάχρησης ουσιών <sup><span class="tooltip" data-tip="Copeland J, Swift W. 2009. Cannabis use disorder: epidemiology and management. International Review of Psychiatry, 21(2), 96-103.">[22]</span></sup>. Όταν οι χρόνιοι χρήστες κάνναβης επιχειρούν απότομη διακοπή, τα σημάδια του συνδρόμου στέρησης (π.χ. η ανησυχία, η ευερεθιστότητα, η ήπια διέγερση, η υπερκινητικότητα, η αϋπνία, η ναυτία, οι κράμπες, η μειωμένη όρεξη, η εφίδρωση και τα αυξημένα όνειρα) είναι κοινά <sup><span class="tooltip" data-tip="Bonnet U &amp; Preuss UW. 2017. The cannabis withdrawal syndrome: current insights. Substance Abuse and Rehabilitation, 8, 9-37.">[23]</span></sup>. </p><h3 id="myth-6"><span class="text-rose-400">Μύθος 6:</span> Η κάνναβη είναι ένα ναρκωτικό που σε βοηθάει να ξεφύγεις από την πραγματικότητα </h3><p> Τα στοιχεία σχετικά με τον πιο πάνω μύθο είναι απροσδιόριστα και η αιτιότητα δεν επιβεβαιώνεται, αλλά αν εξετάσουμε όλους τους ανθρώπους που κάνουν χρήση άλλων ναρκωτικών η πλειοψηφία ξεκίνησε από τη χρήση κάνναβης. Ωστόσο, αυτό δεν σημαίνει ότι εάν κάνει κάποιος χρήση κάνναβης, θα συνεχίσει να χρησιμοποιεί ισχυρότερα ναρκωτικά όπως είναι η κοκαΐνη. Παρόλα αυτά ένα ποσοστό των χρηστών κάνναβης θα χρησιμοποιήσει και ισχυρότερα ναρκωτικά στο μέλλον. </p><p> Αν συγκρίνουμε μάλιστα τη χρήση της κάνναβης με τη χρήση άλλων ναρκωτικών, η κάνναβη χρησιμοποιείται περισσότερο στις περισσότερες χώρες <sup><a href="https://www.emcdda.europa.eu/data/stats2021/gps_en" target="_blank" rel="noopener noreferrer">[24]</a></sup>. Ωστόσο, δεν μπορούμε να συνδέσουμε την μακροχρόνια χρήση της κάνναβης με την πιο πάνω υπόθεση ότι βοηθάει στο να ξεφύγει κανείς από την πραγματικότητα. </p><p> Βέβαια, μία μακροχρόνια μελέτη 25 ετών διαπίστωσε ότι η συχνότητα της χρήσης μαριχουάνας συνδέεται με τη χρήση άλλων παράνομων ναρκωτικών, ιδιαίτερα στους εφήβους <sup><span class="tooltip" data-tip="Fergusson DM, et al. 2006. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction, 101(4), 556-569.">[25]</span></sup>. Επιπλέον, δύο ξεχωριστές μελέτες σε δίδυμα άτομα έκαναν σύγκριση κατά πόσο η πρώιμη χρήση κάνναβης θα οδηγούσε σε κατάχρηση ή εξάρτηση από άλλα παράνομα ναρκωτικά. Τα ευρήματα έδειξαν δύο έως πέντε φορές περισσότερες πιθανότητες να κάνει χρήση το άτομο που έκανε χρήση μαριχουάνας <sup><span class="tooltip" data-tip="Lynskey MT, et al. 2003. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA, 289(4), 427-433.">[26]</span>, <span class="tooltip" data-tip="Agrawal A et al. 2004. Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behavior Genetics, 34(3), 217-228.">[27]</span></sup>. </p><p> Άλλη μία εξήγηση της υπόθεσης ότι αισθάνονται να ξεφεύγουν από την πραγματικότητα, βασίζεται στη νευροβιολογία του εγκεφάλου. Η μειωμένη ευαισθησία ανταμοιβής και η αυξημένη ευαισθησία προσδοκιών κατακλύζουν το κύκλωμα ελέγχου του εγκεφάλου <sup><span class="tooltip" data-tip="Volkow ND, et al. 2010. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain&#39;s control circuit. Bioessays, 32(9), 748-755.">[28]</span></sup>. Με άλλα λόγια, το κύκλωμα μνήμης ανταμείβει τις προσδοκίες μας και ενισχύει το κίνητρο για κατανάλωση του ναρκωτικού. </p><p> Καταλήγοντας, τα στοιχεία είναι διφορούμενα όσον αφορά τον πιο πάνω μύθο, ωστόσο φαίνεται να υπάρχει ο συγκεκριμένος συσχετισμός σε πολλούς χρήστες κάνναβης. </p><h3 id="myth-7"><span class="text-rose-400">Μύθος 7:</span> Δεν μπορεί κάποιος να κάνει υπερβολική χρήση κάνναβης </h3><p> Δεν υπάρχει πιθανότητα να πεθάνει κανείς άμεσα από τη χρήση κάνναβης. Ωστόσο, η υπερβολική δόση μπορεί να προκαλέσει συμπτώματα όπως ναυτία και εμετό, αίσθηση άγχους, παράνοια και βραχυπρόθεσμη ψύχωση (να χάσει επαφή με το περιβάλλον). Τα συμπτώματα αυτά υπάρχει πιθανότητα να διαρκέσουν αρκετές ώρες. Η υπερβολική δόση κάνναβης δεν συμβαίνει συχνά, όμως υπάρχει αυτός ο κίνδυνος εάν κάποιος κάνει χρήση ανεπίσημων προϊόντων κάνναβης. Συμβαίνει καθώς δεν μπορεί να υπολογίσει κανείς εύκολα τη σωστή δόση και το περιεχόμενο των κανναβιδοειδών που περιλαμβάνει. </p><p> Ωστόσο, καθώς η χρήση της κάνναβης στις περισσότερες χώρες είναι πολύ υψηλότερη από άλλα ναρκωτικά, οι παρενέργειες από τη χρήση της έχουν οδηγήσει σε πολύ περισσότερες επισκέψεις στα επείγοντα από άλλες ουσίες <sup><a href=" https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/DAWN2k11ED.pdf" target="_blank" rel="noopener noreferrer">[29]</a></sup>. </p><p> Η υπερβολική χρήση μάλιστα μπορεί να οδηγήσει σε επιδείνωση μίας ψυχιατρικής κατάστασης, ιδιαίτερα στην περίπτωση της ψύχωσης: π.χ. να οδηγήσει σε παράνοια, να αισθάνεται κανείς ότι βλέπει κάτι που δεν υπάρχει, ότι ακούσει κάτι που επίσης δεν υπάρχει ακόμη και σε παραληρητική σκέψη. </p><p> Το κανναβινοειδές THC στην κάνναβη μπορεί επίσης να οδηγήσει σε χειρότερες συνέπειες. Μερικές φορές καταλήγουμε να δίνουμε σε αυτούς τους ανθρώπους αντιψυχωσιτικά φάρμακα και να μειώνουμε σε αυτούς τα συμπτώματα που βιώνουν. Το άλλο πράγμα για το οποίο οι άνθρωποι μπορούν να καταλήψουν στα επείγοντα είναι το σύνδρομο υπερέμεσης κάνναβης (CHS) <sup><a href="https://my.clevelandclinic.org/health/diseases/21665-cannabis-hyperemesis-syndrome" target="_blank" rel="noopener noreferrer">[30]</a></sup>. Το σύνδρομο αυτό περιγράφει την κατάσταση που προκαλείται από τη μακροχρόνια χρήση κάνναβης. Τα άτομα που βιώνουν αυτό το σύνδρομο εμφανίζουν συχνά ναυτία, εμετό, αφυδάτωση, πόνο στην κοιλιά και πολύ συχνά επισκέπτονται το τμήμα επειγόντων περιστατικών. </p><p> Η οξεία τοξικότητα από τη χρήση κάνναβης έχει επίσης μελετηθεί στην Αλάσκα των ΗΠΑ <sup><span class="tooltip" data-tip="Noble MJ et al. 2019. Acute cannabis toxicity. Clinical Toxicology, 57(8), 735-742.">[31]</span></sup> Η νευροτοξιότητα είναι συχνή μετά από οξεία έκθεση στην κάνναβη. Τα παιδιά βιώνουν ακούσιες εκθέσεις στην κάνναβη, ιδιαίτερα μέσα στο σπίτι και περιστασιακά με σοβαρές αρνητικές συνέπειες. </p><p> Τα συμπυκνωμένα προϊόντα όπως οι ρητίνες και τα υγρά συμπυκνώματα έχουν συνδεθεί με μεγαλύτερη τοξικότητα σε σύγκριση με άλλα προϊόντα κάνναβης. </p><p> Ακόμη μία πτυχή που συζητείται στην επιστημονική βιβλιογραφία είναι οι επιπτώσεις της ιατρικής κάνναβης στην υπερβολική δόση οπιοειδών και τη θνησιμότητα. Εδώ τα στοιχεία είναι πραγματικά ανάμικτα <sup><span class="tooltip" data-tip="Shover CL et al. 2019. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences of the United States of America, 116(26), 12624-12626.">[32]</span></sup>. </p><p> Συμπερασματικά, η σύνδεση πρέπει να υπάρχει για αρκετούς χρήστες κάνναβης, όμως πρόκειται μόνο για μελέτες συσχετισμού και η αιτιότητα δεν είναι ξεκάθαρη. </p><h3 id="myth-8"><span class="text-rose-400">Μύθος 8:</span> Ο παθητικός δέκτης του καπνού της κάνναβης είναι ασφαλής </h3><p> Όπως συμβαίνει με κάθε τύπο καπνού που μπορεί να εισπνεύσει ένα άλλο πρόσωπο (παθητικός καπνιστής), οι τοξικές και καρκινογόνες ουσίες του παθητικού καπνίσματος της κάνναβης μπορούν εύκολα να εισπνευστούν από τα παιδιά. Ο καπνός από την κάνναβη περιέχει πολλές χημικές ουσίες όπως ο καπνός του τσιγάρου <sup><span class="tooltip" data-tip="Graves B.M. et al. 2020. Comprehensive characterization of mainstream marijuana and tobacco smoke. Scientific Reports 10(1):7160.">[33]</span></sup> συμπεριλαμβανομένου αυτές που προκαλούν καρκίνο στους πνεύμονες. </p><p> Ο καπνός από την μαριχουάνα επίσης περιέχει THC, μία ουσία που είναι υπεύθυνη για τις περισσότερες ψυχοδραστικές επιδράσεις της κάνναβης. Η ουσία αυτή μπορεί να μεταδοθεί και στα βρέφη και στα παιδιά μέσω του παθητικού καπνίσματος. Επιπλέον τα άτομα που εκτίθενται σε καπνό που προέρχεται από την κάνναβη υπάρχει πιθανότητα να παρουσιάσουν ψυχοδραστικές επιδράσεις καθώς και το αίσθημα της υπερέντασης <sup><span class="tooltip" data-tip="Wilson KM, et al. 2017. Detecting biomarkers of secondhand marijuana smoke in young children. Pediatric Research, 81(4), 589-592.">[34]</span></sup>. </p><p> Πρόσφατες μελέτες διαπιστώνουν ότι υπάρχει υψηλή συσχέτιση μεταξύ του παθητικού καπνίσματος μαριχουάνας (καπνός που προέρχεται από κάποιο γονιό ή συγγενή), και του εντοπισμού της ουσίας THC στα παιδιά <sup><span class="tooltip" data-tip="Moore C, et al. 2011. Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Science International, 212(1-3), 227-230.">[35]</span></sup>. Επιπλέον εντοπίστηκε ότι τα βρέφη που εκτίθενται σε καπνό που προέρχεται από μαριχουάνα κινδυνεύουν σε πρόωρο αιφνίδιο θάνατο (aka SIDS) <sup><span class="tooltip" data-tip="Reece-Stremtan S &amp; Marinelli KA. 2015. ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015. Breastfeeding Medicine, 10(3), 135-141.">[36]</span></sup>. </p><p> Λαμβάνοντας υπόψη τα πιο πάνω γεγονότα, το παθητικό κάπνισμα από την κάνναβη περιλαμβάνει ξεκάθαρα πολλούς κινδύνους για την υγεία. Ωστόσο, συχνά πολλές διαδικτυακές πηγές συμπεραίνουν ότι είναι απίθανο να επηρεαστούν άτομα που έχουν περιορισμένη έκθεση στον καπνό και βρίσκονται σε καλά αεριζόμενο χώρο. Παρόλα αυτά, βασισμένοι σε επιστημονικά γεγονότα, αυτό δεν είναι απόλυτα σίγουρο, ειδικότερα σε κλειστούς χώρους. </p><h3> Άλλε έγκυρες πηγές πληροφόρησης </h3><p><a class="break-all" href="https://www.unodc.org/documents/drug-prevention-and-treatment/cannabis_review.pdf " target="_blank" rel="noopener noreferrer">https://www.unodc.org/documents/drug-prevention-and-treatment/cannabis_review.pdf</a></p>',30);function ta(c,u){const l=h,d=k,o=g,n=v;return r(),p("div",R,[e(d,null,{default:t(()=>[e(l,{class:"w-full lg:max-w-xs print:hidden",key:"drugs-bg-en"})]),_:1}),a("section",W,[e(o,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),U,a("section",$,[z,e(n,{src:"https://evidence.onkel.ee/assets/drugs__cannabis.webp",credits:"Pixabay: https://pixabay.com/photos/marijuana-herbal-cannabis-hemp-5858148/",elevated:!0},{caption:t(()=>[L,s(" Φυτό κάνναβης ")]),_:1}),G,Q,Y,X]),a("section",Z,[aa,e(n,{elevated:"",src:"https://evidence.onkel.ee/assets/drugs__cannabis-medical-effects.webp"},{caption:t(()=>[ea,s(" Επιπτώσεις στην υγεία από τη χρήση κάνναβης. ")]),_:1}),sa,e(n,{elevated:"",src:"https://evidence.onkel.ee/assets/drugs__cannabis-products.webp"},{caption:t(()=>[ia,s(" Κάνναβη και προϊόντα που περιέχουν συγκεντρώσεις από κανναβινοειδή ")]),_:1}),na])])])}const oa=f(V,[["render",ta]]),ra={},la={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},da={class:"e-article",lang:"pt",style:{hyphens:"auto"}},ua=i('<h1 class="mb-0">Drogas</h1><h5 class="font-normal uppercase leading-tight">Informação Científica de Base</h5><section id="s-1"><h2 id="s-1t">Introduction</h2><p class="mt-20"> Este módulo foca-se principalmente na canábis (também conhecida como marijuana, haxixe ou erva, entre outras designações), que é uma droga psicoativa extraída da planta cannabis. </p><p> No texto abaixo, encontra informação para desmistificar mitos comuns acerca da canábis e clarificar as principais questões que lhes estão associadas (o professor / dinamizador da atividade deve ter estas informações presentes ao dinamizar as sessões). </p><h4><a href="#s2">O que é a canábis?</a></h4><ul class="leading-tight"><li class="my-0"><a href="#myth-1">Mito nº 1: A canábis não é assim tão perigosa para a saúde</a></li><li class="my-0"><a href="#myth2">Mito nº 2: A maioria dos jovens pode consumir canábis sem problemas</a></li><li class="my-0"><a href="#myth-3">Mito nº 3. A canábis tem usos medicinais, por isso é uma substância segura para todos</a></li><li class="my-0"><a href="#myth-4">Mito nº 4: A canábis melhora o humor e a saúde mental </a></li><li class="my-0"><a href="#myth5">Mito nº 5: A canábis não provoca dependência</a></li><li class="my-0"><a href="#myth-6">Mito nº 6: A canábis é uma droga de entrada para outras drogas</a></li><li class="my-0"><a href="#myth-7">Mito nº 7: Não se pode ter uma overdose de canábis.</a></li><li class="my-0"><a href="#myth-8">Mito nº 8: O fumo passivo de canábis é seguro</a></li><li class="my-0"><a href="#myth-9">Mito nº 9: A canábis está legalizada em Portugal</a></li></ul></section>',3),pa={id:"s2"},ca=a("h2",{id:"s2t"},"What is cannabis?",-1),ma=a("p",null,[a("span",{class:"e-term"},"Canábis"),s(" (ou marijuana) refere-se a um grupo de três plantas com propriedades psicoativas, conhecidas como Cannabis sativa, Cannabis indica e Cannabis ruderalis. Quando as flores dessas plantas são colhidas e secas, obtém-se uma das drogas mais comuns do mundo. A canábis é composta por mais de 120 compostos, conhecidos como canabinóides. Os dois canabinóides mais conhecidos são o canabidiol (CBD) e o delta-9-tetrahidrocanabinol (THC). O CBD é o segundo composto químico mais prevalente encontrado na cannabis e recentemente tornou-se popular como tratamento alternativo para algumas condições de saúde. Pode ser derivado do "),a("span",{class:"e-term tooltip underline","data-tip":"TO termo cânhamo (hemp) é usado para designar canábis que contem 0.3 porcento ou menos de THC"},"cânhamo"),s(" ou da canábis. O THC é o principal ingrediente psicoativo da canábis. O THC ativa o sistema de recompensa do cérebro ativando a libertação da dopamina química do "),a("a",{class:"e-term",href:"https://nida.nih.gov/publications/research-reports/marijuana/how-does-marijuana-produce-its-effects",target:"_blank",rel:"noopener noreferrer"},"cérebro"),s(". ")],-1),ha=a("b",null,"Figura 1.",-1),ka=a("p",null," Talvez nenhuma outra planta cause tanto debate e equívocos públicos como a canábis. O seu uso e popularidade ao longo dos tempos levaram a que fosse considerada um super medicamento por alguns, estigmatizada como mal na sociedade por outros; e muitos outros pontos de vista dentro deste espectro. Na última década, a legalização da droga para uso recreativo em muitos países e a ampla disponibilidade de informações sobre os benefícios aumentaram ainda mais os equívocos públicos. Existe um grande conjunto de informações disponíveis sobre os seus riscos e também sobre os seus benefícios. Muitas vezes, as informações são dadas na Internet sem as devidas referências. Mais à frente, veremos o que os cientistas e os profissionais de saúde têm a dizer sobre os mitos mais comuns sobre o uso de canábis fundamentados em estudos científicos. ",-1),ga=a("p",null,[s(" More information about the health effects of cannabis can be found from: "),a("a",{class:"break-all",href:"https://docs.google.com/document/d/1kxisOjHc0qINFXhWvmdmMAJyjp7V9JmgfWXDhCKeuyk/edit",target:"_blank",rel:"noopener noreferrer"},"https://docs.google.com/document/d/1kxisOjHc0qINFXhWvmdmMAJyjp7V9JmgfWXDhCKeuyk/edit")],-1),va={id:"s-3"},fa=i('<h2 id="s-3t">Myths about drugs</h2><h3 id="myth-1"><span class="text-rose-400">Mito nº 1:</span> A canábis não é perigosa para a saúde </h3><p> Tem sido argumentado que a canábis não é assim tão perigosa para a saúde, ou mesmo que é benéfica. Este mito está amplamente difundido, tendo como principais explicações as ideias de que as outras drogas são muito mais tóxicas e de que a canábis para fins medicinais está a ser usada como medicamento alternativo em vários países. </p><p> No entanto, de acordo com evidências científicas, a canábis tem sido associada a muitos impactos negativos na saúde (Figura 2). Os riscos mais importantes incluem doenças mentais <sup><span class="tooltip" data-tip="Paruk S &amp; Burns JK. 2016. Cannabis and mental illness in adolescents: a review. South African Family Practice, 58:sup1, S18-S21.">[3]</span></sup>, doenças cardiovasculares <sup><span class="tooltip" data-tip="Thomas G et al. 2014. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. American Journal of Cardiology 113(1):187-190.">[4]</span></sup>, doenças pulmonares <sup><span class="tooltip" data-tip="Joshi M et al. 2014. Marijuana and lung diseases. Current Opinions of Pulmonary Medicine 20(2):173-179.">[5]</span></sup> e cancro dos pulmões e dos testículos <sup><span class="tooltip" data-tip="Joshi M et al. 2014. Marijuana and lung diseases. Current Opinions of Pulmonary Medicine 20(2):173-179.">[6]</span></sup>. Alguns grupos de risco, como os adolescentes e as mulheres grávidas, são especialmente vulneráveis ao uso de canábis. Além disso, o fumo passivo é prejudicial, pois o fumo passivo de canábis é muito semelhante ao fumo do tabaco em termos de propriedades físicas e químicas <sup><span class="tooltip" data-tip="Graves BM et al. 2020. Comprehensive characterization of mainstream marijuana and tobacco smoke. Scientific Reports 10(1):7160.">[7]</span></sup>. O uso de canábis está também relacionado com dependência, aumenta o risco de uso de outras drogas e foram relatadas overdoses. </p>',4),ba=a("b",null,"Figura 2.",-1),ya=i('<h3 id="myth-2"><span class="text-rose-400">Mito nº 2:</span> A maioria dos jovens pode consumir canábis sem problemas </h3><p> Como muitos jovens usam canábis, há uma forte crença de que o seu uso não traz riscos. No entanto, de acordo com diversos estudos, o uso de canábis, especialmente durante a adolescência e início da idade adulta, pode danificar a zona do cérebro associada à aprendizagem e à memória <sup><span class="tooltip" data-tip="Ventura County. 2015. Marijuana and Your Kid’s Brain.” Marijuana in Ventura County: A Gateway for Discussion, Ventura County Behavioral Health. http://venturacountylimits.org.s94613.gridserver.com//resources/article/E413A9/marijuana-and-your-kids-brain-video.">[8]</span></sup>. Alguns estudos sugerem que o uso regular de canábis na adolescência está associado a alterações na conectividade e redução de volume de regiões cerebrais específicas, envolvidas numa ampla gama de funções executivas, como a memória, a aprendizagem e o controle de impulsos, em comparação com pessoas que não usam <sup><span class="tooltip" data-tip="Batalla A et al. 2013. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PloS One 8(2):e55821.">[9]</span></sup>. Igualmente importante, de acordo com estudos, o uso regular de canábis durante a adolescência pode levar a um desempenho escolar pior e a taxas mais altas de abandono escolar <sup><span class="tooltip" data-tip="Fergusson, DM et al. 2010. Cannabis and Educational Achievement: Findings from Three Australian Cohort Studies. Drug and Alcohol Dependence, 110, 3.">[10]</span></sup>. Foi demonstrado que as alterações cerebrais estruturais causadas pelo uso de canábis por adolescentes e jovens adultos são permanentes – os pontos de QI que são perdidos não são recuperados com a idade <sup><span class="tooltip" data-tip="Meier MH et al. 2012. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences of the United States of America, 109:E2657-2664">[11]</span></sup>. O risco do consumo de canábis provocar danos é tanto maior quanto menor a idade de início do consumo e quanto maior a frequência de consumo, bem como a dose e a potência da substância <sup><span class="tooltip" data-tip="Fergusson, D. M., Horwood, L. J., &amp; Swain‐Campbell, N. (2002). Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction, 97(9), 1123-1135.">[12]</span></sup>. A idade é um factor importante pois o funcionamento cognitivo parece ficar mais prejudicado em adolescentes que são consumidores frequentes do que adultos. <sup><span class="tooltip" data-tip="Gorey, C., Kuhns, L., Smaragdi, E., Kroon, E., &amp; Cousijn, J. (2019).">[13]</span></sup></p><h3 id="myth-3"><span class="text-rose-400">Mito nº 3:</span> Se a canábis tem usos medicinais, então é uma substância segura para todos </h3><p> Com base em estudos realizados, as terapias com canabinóides (principalmente contendo CBD) podem ter um papel coadjuvante no controle da ansiedade ou dos distúrbios de stress <sup><span class="tooltip" data-tip="Sharpe L et al. 2020. Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. Journal of Translational Medicine, 18:374">[14]</span></sup>. No entanto, algumas pesquisas também mostraram que pode produzir sentimentos de ansiedade, pânico, paranóia e psicose. Existem atualmente mais três usos reconhecidos para a canábis ou produtos derivados da canábis: náuseas e vómitos relacionados com quimioterapia, anorexia relacionada com fases avançadas do HIV e alguns tipos raros de epilepsia infantil <sup><span class="tooltip" data-tip="National Academies of Sciences, Engineering, and Medicine, 2017. Therapeutic effects of cannabis and cannabinoids. In The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. National Academies Press (US)">[15]</span></sup>. Não há consenso sobre os benefícios para outras situações de saúde, incluindo para doenças psiquiátricas. Está melhor? </p><p> Quando aprovada para fins medicinais, a canábis é um produto específico com concentrações fixas de determinados canabinóides, como canabidiol (CBD) e delta-9-tetrahidrocanabinol (THC) (Figura 3). Além disso, tem vindo a ser discutida a importância da relação CBD/THC. Na canábis medicinal, foi demonstrado que a proporção desempenha um papel crucial na melhoria do bem-estar físico e funcional de pacientes com cancro cerebral <sup><span class="tooltip" data-tip="Schloss J et al. 2021. A phase 2 randomised clinical trial assessing the tolerability of two different ratios of medicinal cannabis in patients with high grade gliomas. Frontiers in Oncology, 11:649555.">[16]</span></sup>. Apenas em produtos sujeitos a controlo farmacêutico a concentração e as doses de CBD e THC podem ser reguladas. </p>',5),wa=a("b",null,"Figura 3.",-1),ja=i('<h3 id="myth-4"><span class="text-rose-400">Mito nº 4:</span> A canábis melhora o humor e promove a saúde mental </h3><p> É sabido que o THC da canábis deixa quem a consome num estado alterado. Pode levar a que o consumidor se sinta feliz, relaxado, a falar ou rir mais do que o normal. Pode achar que as cores e a música são mais brilhantes e nítidas. Os efeitos exatos sobre o humor variam muito de uma pessoa para outra, mas geralmente as emoções são exageradas de uma forma semelhante aos efeitos de intoxicação por álcool <sup><span class="tooltip" data-tip="Gruber SA et al., 2009. Altered affective response in marijuana smokers: An FMRI study. Drug and Alcohol Dependence, 105(1-2), 139-153.">[17]</span></sup>. </p><p> Esses efeitos “positivos” surgem a curto prazo, enquanto o seu uso a longo prazo está associado a um grande número de efeitos negativos sobre a saúde mental. Tal como o álcool, a canábis e os produtos que contêm THC são intoxicantes e podem contribuir para o comprometimento do raciocínio e aumentar a suscetibilidade a problemas de saúde mental, incluindo depressão, insónia e delírio <sup><a class="tooltip" data-tip="National Alliance on Mental Illness (2013) Marijuana and Mental Illness Fact Sheet. Duckworth, K., Freedman, J., reviewers." href="http://www2.nami.org/Content/NavigationMenu/Hearts_and_ Minds/Smoking_Cessation/Marijuana_and_Mental_Illness.htm" target="_blank" rel="noopener noreferrer">[18]</a></sup>. Existe um risco significativo de recaída ou agravamento dos sintomas para indivíduos com transtornos psicóticos <sup><span class="tooltip" data-tip="D’Souza DR. 2015. Medical marijuana: Is the cart before the horse? Journal of the American Medical Association, 313(24), 2431-2432.">[19]</span></sup>. O uso regular de canábis está correlacionado com um risco aumentado e/ou o agravamento dos sintomas em indivíduos com ansiedade, depressão e doença psicótica <sup><span class="tooltip" data-tip="Hill, K. 2015. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. Journal of the American Medical Association, 313(24), 2474-2483.">[20]</span></sup>. Existem algumas evidências que mostram uma ligação entre o uso de canábis mais forte e doenças psicóticas, incluindo esquizofrenia, mas as evidências ainda são escassas e os mecanismos não são totalmente compreendidos <sup><span class="tooltip" data-tip="Patel S. 2020. The association between cannabis use and schizophrenia: causative or curative? A systematic review. Cureus Journal of Medical Science, 12(7), e9309.">[21]</span></sup>. </p><h3 id="myth-5"><span class="text-rose-400">Mito nº 5:</span> A canábis não provoca dependência </h3><p> Este mito é baseado no facto de apenas cerca de 9% dos utilizadores de canábis preencherem os critérios para dependência em algum momento da vida. No entanto, se observarmos as pessoas que começam a usar canábis na adolescência (quando o cérebro ainda está em desenvolvimento e é bastante vulnerável), verifica-se que têm quatro a sete vezes mais probabilidade de desenvolver um distúrbio do que os adultos <sup><span class="tooltip" data-tip="Winters KC &amp; Lee C-YS. 2008. Likelihood of developing an alcohol and cannabis use disorder during youth: Association with recent use and age. Drug and Alcohol Dependence, 92(1-3), 239-247.">[22]</span></sup>. Dados recentes sugerem que 30% dos indivíduos que usam canábis regularmente podem desenvolver algum grau de perturbação associada ao seu uso <sup><span class="tooltip" data-tip="Hasin DS, et al. 2015. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry, 72(12), 1235-1242.">[23]</span></sup>. </p><p> Também foi demonstrado que as variedades atuais de THC são mais fortes, originando dependência fisiológica e síndrome de abstinência, requerendo tratamento específico para abuso de substâncias <sup><span class="tooltip" data-tip="Copeland J, Swift W. 2009. Cannabis use disorder: epidemiology and management. International Review of Psychiatry, 21(2), 96-103.">[24]</span></sup>. Quando utilizadores crónicos de canábis tentam parar abruptamente, os sinais da síndrome de abstinência são comuns: inquietação, irritabilidade, agitação, hiperatividade, insónia, náusea, cólicas, diminuição do apetite, sudorese e aumento dos sonhos <sup><span class="tooltip" data-tip="Bonnet U &amp; Preuss UW. 2017. The cannabis withdrawal syndrome: current insights. Substance Abuse and Rehabilitation, 8, 9-37.">[25]</span></sup>. </p><h3 id="myth-6"><span class="text-rose-400">Mito nº 6:</span> Canábis é uma droga de entrada para outras drogas </h3><p> Aqui, as evidências são pouco claras e a causalidade não está confirmada, mas observa-se que a maioria das pessoas que usam outras drogas começou com canábis. No entanto, isso não significa que quem usa canábis passará a usar outras drogas, mas uma certa percentagem de utilizadores de canábis irá fazê-lo. Se compararmos a prevalência de consumidores de canábis com consumidores de outras drogas, a canábis é muito mais frequente na maioria dos países <sup><a href="https://www.emcdda.europa.eu/data/stats2021/gps_en" target="_blank" rel="noopener noreferrer">[26]</a></sup>. No entanto, com base apenas na prevalência, não podemos estabelecer conexões entre o uso de longo prazo e a hipótese da porta de entrada para outras drogas. </p><p> Um estudo longitudinal de 25 anos descobriu que o uso de canábis está significativamente associado ao abuso e dependência de outras drogas ilícitas, particularmente quando o início é na adolescência <sup><span class="tooltip" data-tip="Fergusson DM, et al. 2006. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction, 101(4), 556-569.">[27]</span></sup>. Dois estudos diferentes com gémeos investigaram se o consumo precoce de canábis tem ou não relação com o abuso ou dependência subsequente de outras drogas ilícitas. Os resultados mostraram um risco duas a cinco vezes maior do gémeo que usava canábis, comparativamente com o que não o fazia <sup><span class="tooltip" data-tip="Lynskey MT, et al. 2003. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA, 289(4), 427-433.">[28]</span>, <span class="tooltip" data-tip="Agrawal A et al. 2004. Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behavior Genetics, 34(3), 217-228.">[29]</span></sup>. </p><p> Outra explicação é baseada na neurobiologia cerebral: a diminuição da sensibilidade à recompensa e o aumento da sensibilidade à expectativa sobrecarregam o circuito de controle do cérebro <sup><span class="tooltip" data-tip="Volkow ND, et al. 2010. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain&#39;s control circuit. Bioessays, 32(9), 748-755.">[30]</span></sup>. Por outras palavras, os circuitos de memória recompensam a expectativa e aumentam a motivação para consumir a droga. Em conclusão, as provas são contraditórias, mas a associação parece existir para muitos consumidores de canábis. </p><h3 id="myth-7"><span class="text-rose-400">Mito nº 7:</span> Não se pode ter uma overdose com canábis </h3><p> Não se morre diretamente de canábis, no entanto é possível ter overdose, ficar fisicamente doente (náuseas, vómitos) e experimentar extrema ansiedade, paranóia e psicose de curto prazo (perda de contacto com a realidade). Estes efeitos podem demorar várias horas a desaparecer. Uma overdose de canábis não acontece com frequência, mas o risco existe quando se consomem produtos não regulados, em que não se pode medir com precisão a dosagem e conteúdo de canabinóides. Como a prevalência do consumo de canábis na maioria dos países é muito mais elevada do que em relação a outras drogas, os efeitos secundários da canábis originam muito mais idas às urgências do que outras substâncias <sup><a href=" https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/DAWN2k11ED.pdf" target="_blank" rel="noopener noreferrer">[31]</a></sup>. </p><p> A overdose também pode resultar no agravamento de uma condição psiquiátrica, particularmente psicose: paranoia, ver e ouvir coisas e pensamentos delirantes. O canabinoide THC da canábis pode piorar esses sintomas, podendo ser necessária medicação antipsicótica para reduzir os sintomas. Um outro motivo para a ida ao serviço de urgência é a Síndrome da Hiperemese por Canabinóides (CHS) <sup><a href="https://my.clevelandclinic.org/health/diseases/21665-cannabis-hyperemesis-syndrome" target="_blank" rel="noopener noreferrer">[32]</a></sup>, uma condição causada pelo consumo prolongado de canábis e que provoca episódios recorrentes de náuseas, vómitos, desidratação e dor abdominal. </p><p> A toxicidade aguda por consumo recreativo de canábis foi estudada no Alasca <sup><span class="tooltip" data-tip="Noble MJ et al. 2019. Acute cannabis toxicity. Clinical Toxicology, 57(8), 735-742.">[33]</span></sup>. A neurotoxicidade é comum após exposições agudas à cannabis. Crianças que estiveram expostas não intencionalmente dentro de casa tiveram, em alguns casos, reações fortemente adversas. Produtos concentrados, como resinas e concentrados líquidos (óleo), foram associados a maior toxicidade do que outros produtos de canábis. Um outro aspeto discutido na literatura científica são os efeitos da canábis medicinal na overdose e mortalidade por opiáceos. Aqui as evidências são realmente mistas e recentemente a associação tem sido questionada <sup><span class="tooltip" data-tip="Shover CL et al. 2019. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences of the United States of America, 116(26), 12624-12626.">[34]</span></sup>. </p><p> Em conclusão, a associação parece existir para vários consumidores de canábis; Mas, novamente, estes são estudos de associação e a causalidade não é clara. </p><h3 id="myth-8"><span class="text-rose-400">Mito nº 8:</span> O fumo passivo de canábis é seguro </h3><p> Como acontece com qualquer outro tipo de fumo passivo <sup><span class="tooltip" data-tip="Graves B.M. et al. 2020. Comprehensive characterization of mainstream marijuana and tobacco smoke. Scientific Reports 10(1):7160.">[35]</span></sup>, as substâncias tóxicas e cancerígenas do fumo passivo de canábis podem ser facilmente inaladas por crianças. Tem muitos produtos químicos, como o fumo do tabaco, incluindo aqueles associados ao cancro de pulmão. </p><p> O fumo passivo da canábis também contém THC, o composto responsável pela maioria dos seus efeitos psicoativos. O THC pode ser transmitido a bebés e crianças através do fumo passivo, e as pessoas expostas ao fumo passivo podem experimentar efeitos psicoativos <sup><span class="tooltip" data-tip="Wilson KM, et al. 2017. Detecting biomarkers of secondhand marijuana smoke in young children. Pediatric Research, 81(4), 589-592.">[36]</span></sup>. Estudos recentes encontraram fortes associações entre relatos de ter alguém em casa que consome canábis (por exemplo, um pai, parente ou cuidador) e a criança ter níveis detectáveis de THC <sup><span class="tooltip" data-tip="Moore C, et al. 2011. Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Science International, 212(1-3), 227-230.">[37]</span></sup>. Foi demonstrado que bebés expostos ao fumo passivo correm o risco de desenvolver a síndrome da morte súbita infantil (também conhecida como SIDS) <sup><span class="tooltip" data-tip="Reece-Stremtan S &amp; Marinelli KA. 2015. ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015. Breastfeeding Medicine, 10(3), 135-141.">[38]</span></sup>. </p><p> Considerando esses factos, o fumo passivo de canábis causa riscos à saúde. No entanto, parece ser improvável que afete pessoas que experimentam exposição limitada em ambientes bem ventilados. </p><h3 id="myth-8"><span class="text-rose-400">Mito nº 9:</span> A cannabis é legal em Portugal </h3><p> O consumo de drogas, incluindo a canábis, é ilegal em Portugal e punido por lei. A lei da descriminalização, Lei nº 30/2000, proíbe e penaliza o consumo de drogas. Descriminalização não significa liberalização, nem tão pouco legalização, a descriminalização significa que o consumo de substâncias ilícitas não é um crime punível com pena de prisão. O consumidor de drogas não é encarado como um criminoso e não vai para a prisão pelo ato de consumir. </p><p> Contudo, sendo o consumo de drogas ilegal, é uma contra-ordenação, punível com as medidas e sanções adequadas ao perfil do consumidor indiciado, como a coima (pagamento de uma multa), proibição de se ausentar para o estrangeiro, apreensão de objectos pessoais, trabalho a favor da comunidade, entre outras medidas. </p><p> Quando uma pessoa é apanhada a consumir canábis, se for maior de 16 anos, a autoridade policial notifica-a para se apresentar na Comissão para a Dissuasão da Toxicodependência (CDT) da área de residência. É instaurado um processo de contra-ordenação em relação ao qual o indiciado consumidor terá de responder, comparecendo na CDT sempre que for notificado, ficando com registo do processo de contra-ordenação por consumo de drogas e decide-se da medida ou sanção a aplicar. Quando se tem menos de 16 anos a polícia encarrega-se de chamar os pais ou representantes legais e de encaminhar o caso para as Comissões de Protecção de Menores. <a href="https://www.sicad.pt/PT/Cidadao/Tu-alinhas/ComportamentosAditivos/Paginas/detalhe.aspx?itemId=1&amp;lista=HistoriaLegislacao&amp;bkUrl=/BK/Cidadao/Tu-alinhas/ComportamentosAditivos" target="_blank" rel="noopener noreferrer"><sup>[39]</sup></a></p><p> Produtos com cannabis para fins medicinais são legais desde que prescritos por médicos e vendidos em farmácias. <a href="https://www.infarmed.pt/web/infarmed/canabis-medicinal" target="_blank" rel="noopener noreferrer"><sup>[40]</sup></a></p><p> Os <b>alimentos derivados da planta Cannabis sativa L autorizados</b> para ser comercializados na União Europeia, e que apresentam histórico de consumo seguro e significativos, são os provenientes <b>exclusivamente das sementes do cânhamo, nomeadamente óleo de sementes, proteína de cânhamo, farinha de cânhamo,</b> e sempre com a premissa que sejam provenientes de variedades de <i>Cannabis sativa</i> L contendo THC inferior a 0,2% (w/w) e <b>desde que não apresentem na sua rotulagem / publicidade alegações de saúde e propriedades terapêuticas.</b> <a href="https://www.asae.gov.pt/newsletter2/asaenews-n-124-novembro-2021/uso.aspx" target="_blank" rel="noopener noreferrer"><sup>[41]</sup></a></p><h3> Outras fontes fiáveis </h3><p><a class="break-all" href="https://www.unodc.org/documents/drug-prevention-and-treatment/cannabis_review.pdf " target="_blank" rel="noopener noreferrer">https://www.unodc.org/documents/drug-prevention-and-treatment/cannabis_review.pdf</a></p>',27);function Ma(c,u){const l=h,d=k,o=g,n=v;return r(),p("div",la,[e(d,null,{default:t(()=>[e(l,{class:"w-full lg:max-w-xs print:hidden",key:"drugs-bg-en"})]),_:1}),a("section",da,[e(o,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),ua,a("section",pa,[ca,ma,e(n,{src:"https://evidence.onkel.ee/assets/drugs__cannabis.webp",credits:"Pixabay: https://pixabay.com/photos/marijuana-herbal-cannabis-hemp-5858148/",elevated:!0},{caption:t(()=>[ha,s(" Plantas de canábis ")]),_:1}),ka,ga]),a("section",va,[fa,e(n,{elevated:"",src:"https://evidence.onkel.ee/assets/drugs__cannabis-medical-effects.webp"},{caption:t(()=>[ba,s(" Cannabis health effects. ")]),_:1}),ya,e(n,{elevated:"",src:"https://evidence.onkel.ee/assets/drugs__cannabis-products.webp"},{caption:t(()=>[wa,s(" Canábis e produtos contendo certas concentrações de canabinóides. ")]),_:1}),ja])])])}const _a=f(ra,[["render",Ma]]),Ca={},Sa={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},Aa={class:"e-article",lang:"sv",style:{hyphens:"auto"}},xa=i('<h1 class="mb-0">Droger</h1><h5 class="font-normal uppercase leading-tight">Vetenskaplig bakgrundsinformation</h5><section id="s-1"><h2 id="s-1t">Introduktion</h2><p class="mt-20"> Modulen är inriktad på cannabis (även känd som marijuana, bland andra namn), som är en psykoaktiv drog från cannabisväxten. </p><p> I texten nedan hittar du förklaringar till följande fakta, myter och missuppfattningar: </p><h4><a href="#s2">Vad är cannabis?</a></h4><ul class="leading-tight"><li class="my-0"><a href="#myth-1">Myt nr 1: Cannabis är inte så farligt för hälsan</a></li><li class="my-0"><a href="#myth2">Myt nr 2: Cannabis är okej för vissa ungdomar</a></li><li class="my-0"><a href="#myth-3">Myt nr 3: Cannabis är en medicinsk drog och därför säker för alla</a></li><li class="my-0"><a href="#myth-4">Myt nr 4: Marijuana hjälper ens humör och främjar mental hälsa</a></li><li class="my-0"><a href="#myth5">Myt nr 5: Cannabis är inte beroendeframkallande</a></li><li class="my-0"><a href="#myth-6">Myt nr 6: Cannabis är en gatewaydrog</a></li><li class="my-0"><a href="#myth-7">Myt nr 7: Du kan inte överdosera cannabis</a></li><li class="my-0"><a href="#myth-8">Myt nr 8: Passiv cannabisrökning är ofarlig</a></li></ul></section>',3),Da={id:"s2"},Ta=i('<h2 id="s2t">Vad är cannabis?</h2><p><span class="e-term">Cannabis</span> Cannabis (eller marijuana) hänvisar till en grupp av tre växter: Cannabis sativa, Cannabis indica och Cannabis ruderalis. När blommorna av dessa växter skördas och torkas, får man en av de vanligaste drogerna i världen. Cannabis består av mer än 120 komponenter, som är kända som cannabinoider. De två mest kända cannabinoiderna är cannabidiol (CBD) och delta-9-tetrahydrocannabinol (THC). CBD är den näst vanligaste kemiska föreningen som finns i cannabis och har nyligen blivit mer populär som en alternativ behandling för ett antal hälsotillstånd. Det kan härröra från <span class="e-term">hampa</span> <sup><span class="tooltip" data-tip="Termen &#39;hampa&#39; används för att betyda cannabis som innehåller 0,3 procent eller mindre THC i torrvikt">[1]</span></sup> eller från cannabis. THC är den huvudsakliga psykoaktiva ingrediensen i cannabis. THC aktiverar hjärnans belöningssystem genom att signalera frisättningen av hjärnkemikalien <span class="e-term">dopamin</span> <a href="https://nida.nih.gov/publications/research-reports/marijuana/how-does-marijuana-produce-its-effects" target="_blank" rel="noopener noreferrer"><sup>[2]</sup></a>. </p>',2),Ia=a("b",null,"Figur 1.",-1),Na=a("p",null," Ingen annan växt orsakar så mycket debatt och offentliga missuppfattningar som cannabis. Dess användning och popularitet genom tiderna har lett till att det blivit stämplat som en supermedicin av vissa och betraktat som ond i samhället av andra. Under det senaste decenniet har legaliseringen av drogen för medicinskbruk i många länder ökat allmänhetens missuppfattningar. Det finns en stor mängd information tillgänglig om dess risker och vice versa om dess fördelar. Ofta ges informationen på Internet utan ordentliga referenser. Därefter kommer vi att titta på vad forskare och medicinsk personal har att säga om de vanligaste myterna om cannabisanvändning med hänvisning till vetenskapliga studier. ",-1),Ha=a("p",null,[a("b",null,"Mer information om hälsoeffekterna av cannabis kan hittas på:"),a("br"),a("a",{class:"break-all",href:"https://docs.google.com/document/d/1TN0kES-b9hDdiZEfVYaftIgjO9G0YoiGleZR04SdvQA/edit?usp=sharing",target:"_blank",rel:"noopener noreferrer"},"https://docs.google.com/document/d/1TN0kES-b9hDdiZEfVYaftIgjO9G0YoiGleZR04SdvQA/edit?usp=sharing")],-1),qa={id:"s-3"},Pa=i('<h2 id="s-3t">Myter om drogar</h2><h3 id="myth-1"><span class="text-rose-400">Myt nr 1:</span> Cannabis är inte så farligt för hälsan </h3><p> Det har hävdats att cannabis inte är så farligt för hälsan. Denna myt är allmänt spridd, med de främsta förklaringarna till att andra droger är mycket giftigare och cannabis används i helande syfte i flera länder. </p><p> Men enligt vetenskapliga bevis har cannabis förknippats med många hälsoeffekter (Figur 2). De viktigaste effekterna är psykisk ohälsa <sup><span class="tooltip" data-tip="Paruk S &amp; Burns JK. 2016. Cannabis och psykisk ohälsa hos ungdomar: en recension. Sydafrikansk familjepraktik, 58:sup1, S18-S21.">[3]</span></sup>, hjärt- och kärlsjukdomar <sup><span class="tooltip" data-tip="Thomas G et al. 2014. Skadliga kardiovaskulära, cerebrovaskulära och perifera vaskulära effekter av marijuanainhalation: vad kardiologer behöver veta. American Journal of Cardiology 113(1):187-190.">[4]</span></sup>, lungsjukdomar <sup><span class="tooltip" data-tip="Joshi M et al. 2014. Marijuana och lungsjukdomar. Current Opinions of Pulmonary Medicine 20(2):173-179.">[5]</span></sup> samt luftvägs- och testikelcancer <sup><span class="tooltip" data-tip="National Academy of Sciences, Engineering and Medicine. 2017. Hälsoeffekterna av cannabis och cannabinoider: det aktuella bevisläget och rekommendationer för forskning. Washington, DC: National Academies Press.">[6]</span></sup>. Vissa riskgrupper som tonåringar och gravida kvinnor är särskilt utsatta för cannabisanvändning. Passiv rökning är också avgörande eftersom rök av cannabis är mycket lik tobaksrök när det gäller fysiska och kemiska egenskaper <sup><span class="tooltip" data-tip="Graves BM et al. 2020. Omfattande karakterisering av vanliga marijuana- och tobaksrök. Scientific Reports 10(1):7160.">[7]</span></sup>. Dessutom är cannabisbruk relaterat till missbruk, det ökar risken för att använda andra droger och överdoser har rapporterats. </p>',4),Ea=a("b",null,"Figur 2.",-1),Ba=i('<h3 id="myth-2"><span class="text-rose-400">Myt nr 2:</span> Cannabis är okej för vissa ungdomar </h3><p> I takt med att många unga använder cannabis, finns det en ökande tro på att det är okej att bli brukare. Men enligt studier kan cannabisanvändning, särskilt under tonåren och tidig vuxen ålder, skada den del av hjärnan som är förknippad med inlärning och minne. Vissa studier tyder på att regelbunden användning av marijuana i tonåren är förknippad med förändrad anslutning och minskad volym av specifika hjärnregioner som är involverade i ett brett spektrum av funktioner som minne <a href="http://venturacountylimits.org.s94613.gridserver.com//resources/article/E413A9/marijuana-and-your-kids-brain-video" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Ventura County. 2015. Marijuana och ditt barns hjärna.” Marijuana i Ventura County: A Gateway for Discussion, Ventura County Behavioral Health."><sup>[8]</sup></a>, inlärning och impulskontroll jämfört med personer som inte använder det <sup><span class="tooltip" data-tip="Batalla A et al. 2013. Strukturella och funktionella avbildningsstudier hos kroniska cannabisanvändare: en systematisk genomgång av ungdoms- och vuxendata. PloS One 8(2):e 55821.">[9]</span></sup>. Viktigast av allt, enligt studier, kan regelbunden cannabisanvändning under tonåren leda till sämre skolprestationer och högre avhopp från skolan <sup><span class="tooltip" data-tip="Fergusson, DM et al. 2010. Cannabis och utbildningsresultat: Resultat från tre australiska kohortstudier. Drog- och alkoholberoende, 110, 3.">[10]</span></sup>. Det har visat sig att de strukturella förändringar i hjärnan som orsakas av cannabisanvändning av ungdomar och unga vuxna är permanenta – IQ-poäng går förlorade och kan inte återställas med åldern <sup><span class="tooltip" data-tip="Meier MH et al. 2012. Ihållande cannabisanvändare visar neuropsykologisk nedgång från barndomen till mitten av livet. Proceedings of the National Academy of Sciences of the United States of America, 109:E 2657-2664">[11]</span></sup>. </p><h3 id="myth-3"><span class="text-rose-400">Myt nr 3.</span> Cannabis är en medicinsk drog och därför säker för alla </h3><p> Det finns för närvarande tre erkända medicinska användningsområden för cannabis eller produkter som härrör från cannabis: illamående och kräkningar relaterade till kemoterapi, anorexi relaterad till framskriden hiv/aids och ett par sällsynta typer av epilepsi i barndomen <sup><span class="tooltip" data-tip="National Academies of Sciences, Engineering, and Medicine, 2017. Terapeutiska effekter av cannabis och cannabinoider. I Hälsoeffekterna av cannabis och cannabinoider: Det aktuella läget för bevis och rekommendationer för forskning. National Academies Press (USA)">[12]</span></sup>. Baserat på tidiga data kan cannabinoidterapier (som i första hand innehåller CBD) ges för behandling av ångest eller stressrelaterade störningar <sup><span class="tooltip" data-tip="Sharpe L et al. 2020. Cannabis, en orsak till ångest? En kritisk bedömning av de anxiogena och anxiolytiska egenskaperna. Journal of Translational Medicine, 18:374.">[13]</span></sup>. Men viss forskning har också visat att det kan ge känslor av ångest, panik, paranoia och psykos. </p><p> Om cannabis är godkänt för helande syfte är det med största sannolikhet en specifik produkt med fasta koncentrationer av specifika cannabinoider som cannabidiol (CBD) och delta-9-tetrahydrocannabinol (THC) (Figur 3). Dessutom har det diskuterats att förhållandet mellan CBD och THC spelar roll. I medicinsk cannabis har det visat sig att ratio spelar en avgörande roll för att förbättra det fysiska och funktionella välbefinnandet hos hjärncancerpatienter <sup><span class="tooltip" data-tip="Schloss J et al. 2021. En randomiserad klinisk prövning i fas 2 som utvärderar tolerabiliteten av två olika kvoter av medicinsk cannabis hos patienter med höggradiga gliom. Frontiers in Oncology, 11:649555.">[14]</span></sup>. Endast i kontrollerade (medicinska) produkter kan CBD- och THC-koncentration och doser kontrolleras. </p>',5),Ka=a("b",null,"Figur 3.",-1),Oa=i('<h3 id="myth-4"><span class="text-rose-400">Myt nr 4:</span> Marijuana hjälper ens humör och främjar mental hälsa </h3><p> Det är välkänt att TBC i cannabis gör en &quot;hög&quot;. Detta kan få en att känna sig glad, avslappnad, pratsam eller skratta mer än vanligt. Man kan upptäcka att färger och musik är ljusare och skarpare. De exakta effekterna på humöret varierar mycket från en person till en annan, men i allmänhet överdrivs känslor på ett liknande sätt som alkoholens berusningseffekter <sup><span class="tooltip" data-tip="Gruber SA et al., 2009. Ändrad affektiv respons hos marijuanarökare: En FMRI-studie. Drug and Alcohol Dependence, 105(1-2), 139-153.">[15]</span></sup>. </p><p> Dessa &quot;positiva&quot; effekter verkar dock vara kortsiktiga, medan långvarig användning är relaterad till ett stort antal negativa effekter på mental hälsa. Liksom alkohol är marijuana och tillhörande THC-innehållande produkter berusande och kan bidra till nedsatt omdöme och ökad mottaglighet för psykiska problem, inklusive depression, sömnlöshet och paranoida vanföreställningar <a href="http://www2.nami.org/Content/NavigationMenu/Hearts_and_Minds/Smoking_Cessation/Marijuana_and_Mental_Illness.htm" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="National Alliance on Mental Illness (2013) Faktablad om marijuana och psykisk ohälsa. Duckworth, K., Freedman, J., reviewers."><sup>[16]</sup></a>. Det finns en betydande risk för återfall eller förvärrade symtom för personer med psykotiska störningar <sup><span class="tooltip" data-tip="D&#39;Souza DR. 2015. Medicinsk marijuana: Står vagnen före hästen? Journal of the American Medical Association, 313(24), 2431-2432">[17]</span></sup>. Regelbunden användning av marijuana är korrelerad med en ökad risk och/eller försämring av symtomen för individer med ångest, depression och psykotiska sjukdomar <sup><span class="tooltip" data-tip="Hill, K. 2015. Medicinsk marijuana för behandling av kronisk smärta och andra medicinska och psykiatriska problem: En klinisk översikt. Journal of the American Medical Association, 313(24), 2474-2483.">[18]</span></sup>. Det finns vissa bevis på ett samband mellan användningen av starkare cannabis och psykotiska sjukdomar, inklusive schizofreni, men bevisen är fortfarande knappa och mekanismerna är inte helt klarlagda <sup><span class="tooltip" data-tip="Patel S. 2020. Sambandet mellan cannabisanvändning och schizofreni: orsakande eller botande? En systematisk review. Cureus Journal of Medical Science, 12(7), e9309">[19]</span></sup>. </p><h3 id="myth-5"><span class="text-rose-400">Myt nr 5:</span> Cannabis är inte beroendeframkallande </h3><p> Av alla människor som använder marijuana kommer endast cirka 9% att uppfylla kriterierna för missbruk någon gång i livet. Men om du tittar på personer som börjar använda marijuana som tonåringar (när hjärnan fortfarande utvecklas och är ganska sårbar), så har de fyra till sju gånger större risk att utveckla en cannabisberoende än vuxna <sup><span class="tooltip" data-tip="Winters KC &amp; Lee C-YS. 2008. Sannolikhet att utveckla en alkohol- och cannabismissbruksstörning under ungdom: Samband med nyligen användande och ålder. Drug and Alcohol Dependence, 92(1-3), 239-247">[20]</span></sup>. Nya uppgifter tyder på att 30 % av dem som använder cannabis regelbundet kan ha en viss grad av störning <sup><span class="tooltip" data-tip="Hasin DS, et al. 2015. Prevalensen av marijuanamissbruk i USA mellan 2001-2002 och 2012-2013. JAMA Psychiatry, 72(12), 1235-1242">[21]</span></sup>. </p><p> Det har också visat sig att dagens stammar av THC är starkare – och nu producerar fysiologiskt beroende och abstinens som kräver missbruksbehandling <sup><span class="tooltip" data-tip="Copeland J, Swift W. 2009. Cannabisanvändningsstörning: epidemiologi och hantering. International Review of Psychiatry, 21(2), 96-103">[22]</span></sup>. När kroniska cannabisanvändare försöker abrupt avbryta behandlingen är tecknen på abstinenssyndrom – rastlöshet, irritabilitet, hyperaktivitet, sömnlöshet, illamående, kramper, minskad aptit, svettning och ökat drömmande – vanliga <sup><span class="tooltip" data-tip="Motorhuv U &amp; Preuss UW. 2017. Cannabisabstinenssyndromet: aktuella insikter. Missbruk och rehabilitering, 8, 9-37">[23]</span></sup>. </p><h3 id="myth-6"><span class="text-rose-400">Myt nr 6:</span> Cannabis är en gatewaydrog </h3><p> Här, kausaliteten är inte bekräftad, men om vi tittar på alla personer som använder andra droger så har de flesta börjat med cannabis. Det betyder dock inte att om du använder cannabis kommer du att fortsätta att använda starkare droger som kokain. Men en viss procentandel av cannabisanvändarna kommer att göra det. Om vi jämför förekomsten av cannabis med andra droganvändare är cannabis mycket vanligare i de flesta länder <a href="https://www.emcdda.europa.eu/data/stats2021/gps_en" target="_blank" rel="noopener noreferrer"><sup>[24]</sup></a>. Men baserat på enbart prevalens kan vi inte dra samband mellan långvarig användning och gateway-hypotesen. </p><p> En 25-årig longitudinell studie har emellertid funnit att frekvensen av marijuanaanvändning är signifikant jämfört med andra olagliga droger för missbruk och beroende - särskilt hos tonåringar <sup><span class="tooltip" data-tip="Fergusson DM, et al. 2006. Cannabisanvändning och annan olaglig droganvändning: testa cannabis gateway-hypotesen. Beroende, 101(4), 556-569.">[25]</span></sup>. Två separata studier av tvillingar har jämfört huruvida tidig cannabisanvändning ledde till efterföljande missbruk eller beroende av andra olagliga droger. Resultaten visade två till fem gånger större risk än för en tvilling som inte använde marijuana. <sup><span class="tooltip" data-tip="Lynskey MT, et al. 2003. Upptrappning av droganvändning hos cannabisanvändare som börjar tidigt kontra tvillingkontroller. JAMA, 289(4), 427-433.">[26]</span></sup> <sup><span class="tooltip" data-tip="Agrawal A et al. 2004. Cannabis och andra olagliga droger: komorbid användning och missbruk/beroende hos män och kvinnor. Behavior Genetics, 34(3), 217-228">[27]</span></sup></p><p> En annan förklaring av gateways och beroenden är baserad på hjärnans neurobiologi – minskad belöningskänslighet och ökad förväntningskänslighet överväldigar hjärnans kontrollkrets <sup><span class="tooltip" data-tip="Volkow ND, et al. 2010. Beroende: minskad belöningskänslighet och ökad förväntningskänslighet konspirerar för att överväldiga hjärnans kontrollkrets. Bioessays, 32(9), 748-755">[28]</span></sup>. Med andra ord, minnet driver våra förväntningar och ökar motivationen att konsumera drogen. Sammanfattningsvis, bevisen är blandade, men det verkar finnas ökad risk för missbruk av andra droger för många cannabisanvändare. </p><h3 id="myth-7"><span class="text-rose-400">Myt nr 7:</span> Du kan inte överdosera cannabis </h3><p> Man kan inte dö direkt av cannabis; dock kan man överdosera, bli fysiskt sjuk (illamående, kräkningar) och uppleva extrem ångest, paranoia och kortvarig psykos (förlust av kontakt med verkligheten). Dessa effekter kan ta flera timmar att försvinna. En överdos av cannabis händer inte ofta, men risken finns om du konsumerar inofficiella cannabisprodukter. Som vanligt kan man inte exakt mäta din dosering och innehåll av cannabinoider. Ändå, eftersom prevalensen av cannabisanvändning i de flesta länder är mycket högre än andra droger, har biverkningarna av cannabis lett till mycket fler akutbesök än andra substanser <a href="https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/DAWN2k11ED.pdf" target="_blank" rel="noopener noreferrer"><sup>[29]</sup></a>. </p><p> Överdosen kan också resultera i försämring av brukarnas psykiatriska tillstånd, särskilt psykos: detta återspeglas i paranoia, se saker, höra saker, vanföreställningar. Cannabinoiden THC i cannabis kan göra det värre. Ibland blir vi tvungna att ge dessa människor antipsykotiska mediciner för att minska symtomen. Det andra som människor kan hamna på akuten för är cannabis hyperemesis syndrome (CHS) <a href="https://my.clevelandclinic.org/health/diseases/21665-cannabis-hyperemesis-syndrome" target="_blank" rel="noopener noreferrer"><sup>[30]</sup></a>. CHS är ett tillstånd som orsakas av långvarigt cannabisbruk. Personer som har CHS upplever återkommande episoder av illamående, kräkningar, uttorkning och buksmärtor, med täta besök på akutmottagningen. </p><p> Akut toxicitet av fritids cannabis har också studerats i Alaska, USA <sup><span class="tooltip" data-tip="Noble MJ et al. 2019. Akut cannabistoxicitet. Clinical Toxicology, 57(8), 735-742">[31]</span></sup> Neurotoxicitet är vanlig efter akuta cannabisexponeringar. Barn upplevde oavsiktlig exponering, särskilt i hemmet och ibland med allvarliga negativa resultat. Koncentrerade produkter som hartser och flytande koncentrat var förknippade med större toxicitet än andra cannabisprodukter. En annan aspekt som diskuteras i den vetenskapliga litteraturen är medicinska cannabiseffekter på opioidöverdos och dödlighet. Här är bevisningen riktigt blandad. <sup><span class="tooltip" data-tip="Shover CL et al. 2019. Sambandet mellan medicinsk cannabislagstiftning och dödlighet i opioidöverdos har vänt över tiden. Proceedings of the National Academy of Sciences of the United States of America, 116(26), 12624-12626">[32]</span></sup></p><h3 id="myth-8"><span class="text-rose-400">Myt nr 8:</span> Passiv cannabisrökning är ofarlig </h3><p> Som med alla andra typer av passiv rökning kan <sup><span class="tooltip" data-tip="Graves BM et al. 2020. Omfattande karakterisering av vanliga marijuana- och tobaksrök. Scientific Reports 10(1):7160">[33]</span></sup> de giftiga ämnena och cancerframkallande ämnena i cannabis rök lätt inandas av barn. Det har många kemikalier som tobaksrök, inklusive de som är kopplade till lungcancer. Marijuana rök innehåller också THC, den förening som ansvarar för de flesta av cannabiss psykoaktiva effekter. Det kan överföras till spädbarn och barn genom passiv rökning, och personer som utsätts för passiv cannabisrök kan uppleva psykoaktiva effekter, som att känna sig hög <sup><span class="tooltip" data-tip="Wilson KM, et al. 2017. Upptäcker biomarkörer för begagnad marijuanarök hos små barn. Pediatric Research, 81(4), 589-592">[34]</span></sup>. Nyligen genomförda studier har funnit starka samband mellan rapporter om att någon i hemmet använder marijuana (t.ex. en förälder, släkting eller vårdnadshavare) och att barnet har påvisbara nivåer av THC <sup><span class="tooltip" data-tip="Moore C, et al. 2011. Cannabinoider i munvätska efter passiv exponering för marijuanarök. Forensic Science International, 212(1-3), 227-230">[35]</span></sup>. Det har visat sig att spädbarn som utsätts för passiv marijuanarök löper risk att drabbas av plötslig spädbarnsdöd (alias SIDS). <sup><span class="tooltip" data-tip="Reece- Stremtan S &amp; Marinelli KA. 2015. ABM clinical protocol #21: guidelines for breastfeeding and drug use or drug use disorder, revised 2015. Breastfeeding Medicine, 10(3), 135-141">[35]</span></sup></p><p> Med dessa fakta orsakar passiv rökning hälsorisker. Men flera webbsidor drar ofta slutsatsen att det är osannolikt att det påverkar människor under begränsad exponering i en välventilerad miljö. Baserat på vetenskapliga fakta är detta inte sant, särskilt inte i en inomhusmiljö. </p><h3> Andra pålitliga källor </h3><p><a class="break-all" href="https://www.unodc.org/documents/drug-prevention-and-treatment/cannabis_review.pdf " target="_blank" rel="noopener noreferrer">https://www.unodc.org/documents/drug-prevention-and-treatment/cannabis_review.pdf</a></p>',19);function Ja(c,u){const l=h,d=k,o=g,n=v;return r(),p("div",Sa,[e(d,null,{default:t(()=>[e(l,{class:"w-full lg:max-w-xs print:hidden",key:"drugs-bg-en"})]),_:1}),a("section",Aa,[e(o,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),xa,a("section",Da,[Ta,e(n,{src:"https://evidence.onkel.ee/assets/drugs__cannabis.webp",credits:"Pixabay: https://pixabay.com/photos/marijuana-herbal-cannabis-hemp-5858148/",elevated:!0},{caption:t(()=>[Ia,s(" Cannabisväxter ")]),_:1}),Na,Ha]),a("section",qa,[Pa,e(n,{elevated:"",src:"https://evidence.onkel.ee/assets/drugs__cannabis-medical-effects.webp"},{caption:t(()=>[Ea,s(" Cannabis hälsoeffekter ")]),_:1}),Ba,e(n,{elevated:"",src:"https://evidence.onkel.ee/assets/drugs__cannabis-products.webp"},{caption:t(()=>[Ka,s(" Cannabis och produkter som innehåller vissa koncentrationer av cannabinoider. ")]),_:1}),Oa])])])}const Fa=f(Ca,[["render",Ja]]),Va={},Ra={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},Wa={class:"e-article",lang:"en",style:{hyphens:"auto"}},Ua=i('<h1 class="mb-0">Drugs</h1><h5 class="font-normal uppercase leading-tight">Scientific background information</h5><section id="s-1"><h2 id="s-1t">Introduction</h2><p class="mt-20"> The module is mainly focused on cannabis (also known as marijuana, among other names), which is a psychoactive drug from the cannabis plant. An alternative pathway to be followed in this module is the scandalous substance called MMS (Miracle Mineral Drug) which is a branded name for an aqueous solution of chlorine dioxide, an industrial bleaching agent, that has been falsely promoted as a cure for illnesses, including HIV, cancer, COVID-19, and the common cold, but also autism. </p><p> In the text below, you will find explanations for the following issues: </p><h4><a href="#section-1">What is cannabis?</a></h4><ul class="leading-tight"><li class="my-0"><a href="#myth-1">Myth No 1: Cannabis isn’t that dangerous for health</a></li><li class="my-0"><a href="#myth2">Myth No2: Cannabis is okay for some youth.</a></li><li class="my-0"><a href="#myth-3">Myth No 3. Cannabis is a medical drug and, therefore, safe for everybody</a></li><li class="my-0"><a href="#myth-4">Myth No 4: Marijuana helps one’s mood and promotes mental health</a></li><li class="my-0"><a href="#myth5">Myth No 5: Cannabis is not addictive</a></li><li class="my-0"><a href="#myth-6">Myth No 6: Cannabis is a gateway drug</a></li><li class="my-0"><a href="#myth-7">Myth No 7: You cannot overdose on cannabis</a></li><li class="my-0"><a href="#myth-8">Myth No 8: Secondhand cannabis smoke is safe</a></li></ul><h4><a href="#section-2">What is MMS?</a></h4><ul class="leading-tight"><li class="my-0"><a href="#safety">Safety</a></li><li class="my-0"><a href="#miracle-drug">Marketing as a “miracle drug”</a></li><li class="my-0"><a href="#myth-9">Myth No 9: MMS cures COVID-19</a></li><li class="my-0"><a href="#myth-10">Myth No 10: MMS cures autism</a></li></ul></section>',3),$a={id:"s-2"},za=a("h2",{id:"s-2t"},"What is cannabis?",-1),La=a("p",null,[a("span",{class:"e-term"},"Cannabis"),s(" (or marijuana) refers to a group of three plants with psychoactive properties, known as Cannabis sativa, Cannabis indica, and Cannabis ruderalis. When the flowers of these plants are harvested and dried, you’re left with one of the most common drugs in the world. Cannabis is made up of more than 120 components, which are known as cannabinoids. The two most well-known cannabinoids are cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). CBD is the second most prevalent chemical compound found in cannabis and has recently become more popular as an alternative treatment for a number of conditions. It can be derived from "),a("span",{class:"e-term tooltip underline","data-tip":"The term “hemp” is used to mean cannabis that contains 0.3 percent or less THC content by dry weight"},"hemp"),s(" or from cannabis. THC is the main psychoactive ingredient in cannabis. THC activates the brain's reward system by signalling the release of the brain chemical "),a("a",{class:"e-term",href:"https://nida.nih.gov/publications/research-reports/marijuana/how-does-marijuana-produce-its-effects",target:"_blank",rel:"noopener noreferrer"},"dopamine"),s(". ")],-1),Ga=a("b",null,"Figure 1:",-1),Qa=a("p",null," Perhaps no other plant causes as much debate and public misconceptions as cannabis. Its usage and popularity throughout the ages has led to it being branded a super medicine by some, stigmatised as evil in society by others; and many other points of view within that spectrum. In the last decade the legalization of the drug for recreational use in many countries and largely available information on the benefits, have even increased public misconceptions. There is a large set of information available on its risks and vice versa on its benefits. Often the information is given on the Internet without proper references. Subsequently, we will look at what scientists and medical personnel have to say about the most common myths about cannabis usage referring to scientific studies. ",-1),Ya=a("p",null,[s(" More information about the health effects of cannabis can be found from: "),a("a",{class:"break-all",href:"https://docs.google.com/document/d/1kxisOjHc0qINFXhWvmdmMAJyjp7V9JmgfWXDhCKeuyk/edit",target:"_blank",rel:"noopener noreferrer"},"https://docs.google.com/document/d/1kxisOjHc0qINFXhWvmdmMAJyjp7V9JmgfWXDhCKeuyk/edit")],-1),Xa={id:"s-3"},Za=i('<h2 id="s-3t">Myths about drugs</h2><h3 id="myth-1"><span class="text-rose-400">Myth No 1:</span> Cannabis isn’t that dangerous for health </h3><p> It has been argued that cannabis is not that dangerous for health, even beneficial. This myth is widely spread, with the main explanations of other drugs being much more toxic and cannabis usage for healing purposes as an alternative drug in several countries. </p><p> However, according to scientific evidence, cannabis has been associated with many health effects (Figure 2). The most important effects include mental illness <sup><span class="tooltip" data-tip="Paruk S &amp; Burns JK. 2016. Cannabis and mental illness in adolescents: a review. South African Family Practice, 58:sup1, S18-S21.">[3]</span></sup>, cardiovascular diseases <sup><span class="tooltip" data-tip="Thomas G et al. 2014. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Americal Journal of Cardiology 113(1):187-190.">[4]</span></sup>, lung diseases <sup><span class="tooltip" data-tip=" Joshi M et al. 2014. Marijuana and lung diseases. Current Opinions of Pulmonary Medicine 20(2):173-179.">[5]</span></sup> and respiratory and testicular cancer <sup><span class="tooltip" data-tip="Joshi M et al. 2014. Marijuana and lung diseases. Current Opinions of Pulmonary Medicine 20(2):173-179. ">[6]</span></sup>. Some risk groups as teens and pregnant women, are especially vulnerable to cannabis usage. Also, passive smoking is vital as cannabis second-hand smoke is very similar to tobacco smoke in terms of physical and chemical properties <sup><span class="tooltip" data-tip="Graves BM et al. 2020. Comprehensive characterization of mainstream marijuana and tobacco smoke. Scientific Reports 10(1):7160.">[7]</span></sup>. Moreover, cannabis use is related to addiction, it increases the risk of using other drugs, and overdoses have been reported. </p>',4),ae=a("b",null,"Figure 2.",-1),ee=i('<h3 id="myth-2"><span class="text-rose-400">Myth No2:</span> Cannabis is okay for some youth </h3><p> As many young people use cannabis, there is increasing belief that it is okay to be used. However, according to studies, cannabis use, especially during adolescence and early adulthood, can damage the part of the brain associated with learning and memory <sup><span class="tooltip" data-tip="Ventura County. 2015. Marijuana and Your Kid’s Brain.” Marijuana in Ventura County: A Gateway for Discussion, Ventura County Behavioral Health. http:// venturacountylimits.org.s94613.gridserver.com//resources/ article/E413A9/marijuana-and-your-kids-brain-video.">[8]</span></sup>. Some studies suggest regular marijuana use in adolescence is associated with altered connectivity and reduced volume of specific brain regions involved in a broad range of executive functions such as memory, learning, and impulse control compared to people who do not use <sup><span class="tooltip" data-tip="Batalla A et al. 2013. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PloS One 8(2):e55821.">[9]</span></sup>. Most importantly, according to studies, regular cannabis use during adolescence can lead to poorer school performance and higher school dropout rates <sup><span class="tooltip" data-tip="Fergusson, DM et al. 2010. Cannabis and Educational Achievement: Findings from Three Australian Cohort Studies. Drug and Alcohol Dependence, 110, 3.">[10]</span></sup>. It has been shown that the structural brain changes caused by cannabis use by adolescents and young adults are permanent – IQ points are lost and cannot be recovered with age <sup><span class="tooltip" data-tip="Meier MH et al. 2012. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences of the United States of America, 109:E2657-2664">[11]</span></sup>. … </p><h3 id="myth-3"><span class="text-rose-400">Myth No 3.</span> Cannabis is a medical drug and, therefore, safe for everybody </h3><p> There are currently three more recognized uses for cannabis or cannabis-derived products: nausea and vomiting related to chemotherapy, anorexia related to advance HIV/AIDS, and a couple of rare types of childhood epilepsy <sup><span class="tooltip" data-tip="National Academies of Sciences, Engineering, and Medicine, 2017. Therapeutic effects of cannabis and cannabinoids. In The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. National Academies Press (US)">[12]</span></sup>. All else, including psychiatric conditions, is not widely approved. Based on early data, cannabinoid therapies (containing CBD primarily) may provide a more suitable treatment for people with pre-existing anxiety or as a potential adjunctive role in managing anxiety or stress-related disorders <sup><span class="tooltip" data-tip="Sharpe L et al. 2020. Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. Journal of Translational Medicine, 18:374.">[13]</span></sup>. However, certain research has also shown that it can produce feelings of anxiety, panic, paranoia and psychosis. </p><p> If cannabis is approved for healing purposes, it is most likely a specific product with fixed concentrations of specific cannabinoids such as cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) (Figure 3). Furthermore, it has been discussed that the CBD/THC ratio matters. In medicinal cannabis, it has been shown ratio plays a crucial role in improving the physical and functional well-being of brain cancer patients <sup><span class="tooltip" data-tip="Schloss J et al. 2021. A phase 2 randomised clinical trial assessing the tolerability of two different ratios of medicinal cannabis in patients with high grade gliomas. Frontiers in Oncology, 11:649555.">[14]</span></sup>. Only in controlled (medical) products CBD and THC concentration and doses can be controlled. </p>',5),se=a("b",null,"Figure 3.",-1),ie=i('<h3 id="myth-4"><span class="text-rose-400">Myth No 4:</span> Marijuana helps one’s mood and promotes mental health </h3><p> It is well known that TBC in cannabis makes one ‘high’. This can make one feel happy, relaxed, talkative or laugh more than usual. One may find that colours and music are brighter and sharper. The exact effects on mood vary greatly from one person to another, but generally, emotions are exaggerated in a similar way to the intoxication effects of alcohol <sup><span class="tooltip" data-tip="Gruber SA et al., 2009. Altered affective response in marijuana smokers: An FMRI study. Drug and Alcohol Dependence, 105(1-2), 139-153.">[15]</span></sup>. </p><p> However, those “positive” effects appear short-term, whereas long-term usage is related to a large number of negative effects on mental health. Like alcohol, marijuana and associated THC-containing products are intoxicants and can contribute to impaired judgment and increased susceptibility to mental health problems, including depression, insomnia and paranoid delusions <sup><a class="tooltip" data-tip="National Alliance on Mental Illness (2013) Marijuana and Mental Illness Fact Sheet. Duckworth, K., Freedman, J., reviewers." href="http://www2.nami.org/Content/NavigationMenu/Hearts_and_ Minds/Smoking_Cessation/Marijuana_and_Mental_Illness.htm" target="_blank" rel="noopener noreferrer">[16]</a></sup>. There is a significant risk of relapse or worsening of symptoms for individuals with psychotic disorders <sup><span class="tooltip" data-tip="D’Souza DR. 2015. Medical marijuana: Is the cart before the horse? Journal of the American Medical Association, 313(24), 2431-2432.">[17]</span></sup>. Regular marijuana use is correlated with an increased risk and/or worsening of the symptoms for individuals with anxiety, depression and psychotic illnesses <sup><span class="tooltip" data-tip="Hill, K. 2015. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. Journal of the American Medical Association, 313(24), 2474-2483.">[19]</span></sup>. There is some evidence to show a link between the use of stronger cannabis and psychotic illnesses, including schizophrenia, but the evidence is still scarce and mechanisms are not fully understood <sup><span class="tooltip" data-tip="Patel S. 2020. The association between cannabis use and schizophrenia: causative or curative? A systematic review. Cureus Journal of Medical Science, 12(7), e9309.">[19]</span></sup>. </p><h3 id="myth-5"><span class="text-rose-400">Myth No 5:</span> Cannabis is not addictive </h3><p> The myth is based on fact at of all the people who use marijuana, only about 9% will meet the criteria for addiction at some point in their lives. However, if you look at people who start using marijuana as adolescents (when the brain is still developing and is quite vulnerable), then they have four to seven times more likely to develop a cannabis disorder than adults <sup><span class="tooltip" data-tip="Winters KC &amp; Lee C-YS. 2008. Likelihood of developing an alcohol and cannabis use disorder during youth: Association with recent use and age. Drug and Alcohol Dependence, 92(1-3), 239-247.">[20]</span></sup>. Recent data suggest that 30% of those who use cannabis regularly may have some degree of use disorder <sup><span class="tooltip" data-tip="Hasin DS, et al. 2015. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry, 72(12), 1235-1242.">[21]</span></sup>. </p><p> It has also been shown that today’s strains of THC are stronger – and now produce physiological dependence and withdrawal that requires substance abuse treatment <sup><span class="tooltip" data-tip="Copeland J, Swift W. 2009. Cannabis use disorder: epidemiology and management. International Review of Psychiatry, 21(2), 96-103.">[22]</span></sup>. When chronic cannabis users attempt abrupt discontinuation, the signs of withdrawal syndrome – restlessness, irritability, mild agitation, hyperactivity, insomnia, nausea, cramping, decreased appetite, sweating and increased dreaming – are common <sup><span class="tooltip" data-tip="Bonnet U &amp; Preuss UW. 2017. The cannabis withdrawal syndrome: current insights. Substance Abuse and Rehabilitation, 8, 9-37.">[23]</span></sup>. </p><h3 id="myth-6"><span class="text-rose-400">Myth No 6:</span> Cannabis is a gateway drug </h3><p> Here, the evidence is undefined, and causality is not confirmed, but if we look at all the people who use other drugs, most of them have started with cannabis. Nevertheless, this does not mean that if you use cannabis, you will go on to use stronger drugs such as cocaine. But some percentage of cannabis users will do. If we compare the prevalence of cannabis with other drug users, cannabis is much more common in most countries <sup><a href="https://www.emcdda.europa.eu/data/stats2021/gps_en" target="_blank" rel="noopener noreferrer">[24]</a></sup>. However, based on prevalence alone, we cannot draw connections between long-term usage and the gateway hypothesis. </p><p> However, a 25-year longitudinal study has found the frequency of marijuana use to be significant with other illicit drugs of abuse and dependence – particularly with adolescent-onset use <sup><span class="tooltip" data-tip="Fergusson DM, et al. 2006. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction, 101(4), 556-569.">[25]</span></sup>. Two separate studies of twins have compared whether or not early cannabis use showed subsequent abuse or dependence on other illicit drugs. The findings showed two to five times greater risk than that of a twin who did not use marijuana <sup><span class="tooltip" data-tip="Lynskey MT, et al. 2003. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA, 289(4), 427-433.">[26]</span>, <span class="tooltip" data-tip="Agrawal A et al. 2004. Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behavior Genetics, 34(3), 217-228.">[27]</span></sup>. </p><p> Another explanation of gateways and addictions is based on brain neurobiology – decreased reward sensitivity and increased expectation sensitivity overwhelm the brain&#39;s control circuit <sup><span class="tooltip" data-tip="Volkow ND, et al. 2010. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain&#39;s control circuit. Bioessays, 32(9), 748-755.">[28]</span></sup>. In other words, the memory circuit drives reward our expectation and enhance the motivation to consume the drug. In conclusion, the evidence is mixed, but the association seems to be there for many cannabis users. </p><h3 id="myth-7"><span class="text-rose-400">Myth No 7:</span> You cannot overdose on cannabis </h3><p> One cannot die directly from cannabis; however, one can overdose, become physically ill (nausea, vomiting), and experience extreme anxiety, paranoia, and short-term psychosis (loss of touch with reality). These effects can take several hours to go away. An overdose of cannabis does not happen often, but the risk exists if you consume unofficial cannabis products. As usual, one cannot accurately measure your dosage and cannabinoid content. Nevertheless, as the cannabis usage prevalence in most countries is much higher than other drugs, the side effects of cannabis have led to far more emergency room visits than other substances <sup><a href=" https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/DAWN2k11ED.pdf" target="_blank" rel="noopener noreferrer">[29]</a></sup>. </p><p> The overdose can also result in worsening of their psychiatric condition, particularly psychosis: this reflects in paranoia, seeing things, hearing things, delusional thinking. The cannabinoid THC in cannabis can make that worse. Sometimes we end up having to give these people antipsychotic medications to reduce the symptoms and get them comfortable. The other thing people can end up in the ER for is cannabis hyperemesis syndrome (CHS) <sup><a href="https://my.clevelandclinic.org/health/diseases/21665-cannabis-hyperemesis-syndrome" target="_blank" rel="noopener noreferrer">[30]</a></sup>. CHS is a condition caused by long-term cannabis use. People who have CHS experience reoccurring episodes of nausea, vomiting, dehydration and abdominal pain, with frequent visits to the emergency department. </p><p> Acute toxicity of recreational cannabis has also been studied in Alaska, the U.S. <sup><span class="tooltip" data-tip="Noble MJ et al. 2019. Acute cannabis toxicity. Clinical Toxicology, 57(8), 735-742.">[31]</span></sup>Neurotoxicity is common after acute cannabis exposures. Children experienced unintentional exposures, particularly within the home and occasionally with major adverse outcomes. Concentrated products such as resins and liquid concentrates were associated with greater toxicity than other cannabis products. Another aspect discussed in scientific literature is medical cannabis effects on opioid overdose and mortality. Here the evidence is really mixed and recently the association have been questioned <sup><span class="tooltip" data-tip="Shover CL et al. 2019. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences of the United States of America, 116(26), 12624-12626.">[32]</span></sup>. </p><p> In conclusion, the association seems to be there for several cannabis users; but again, these are studies of association and the causation is not clear. </p><h3 id="myth-8"><span class="text-rose-400">Myth No 8:</span> Secondhand cannabis smoke is safe </h3><p> As with any other type of secondhand smoke <sup><span class="tooltip" data-tip="Graves B.M. et al. 2020. Comprehensive characterization of mainstream marijuana and tobacco smoke. Scientific Reports 10(1):7160.">[33]</span></sup>, the toxic substances and carcinogens in cannabis secondhand smoke can easily be inhaled by children. It has many chemicals like tobacco smoke, including those linked to lung cancer. </p><p> Secondhand marijuana smoke also contains THC, the compound responsible for most of cannabis&#39;s psychoactive effects. It can be passed to infants and children through secondhand smoke, and people exposed to secondhand cannabis smoke can experience psychoactive effects, such as feeling high <sup><span class="tooltip" data-tip="Wilson KM, et al. 2017. Detecting biomarkers of secondhand marijuana smoke in young children. Pediatric Research, 81(4), 589-592.">[34]</span></sup>. Recent studies have found strong associations between reports of having someone in the home who uses marijuana (e.g., a parent, relative, or caretaker) and the child having detectable levels of THC <sup><span class="tooltip" data-tip="Moore C, et al. 2011. Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Science International, 212(1-3), 227-230.">[35]</span></sup>. It has been shown that infants who are exposed to secondhand marijuana smoke are at risk of sudden infant death syndrome (aka SIDS) <sup><span class="tooltip" data-tip="Reece-Stremtan S &amp; Marinelli KA. 2015. ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015. Breastfeeding Medicine, 10(3), 135-141.">[36]</span></sup>. </p><p> Taking those facts, secondhand cannabis smoke causes health risks. However, several web pages frequently conclude that it is unlikely to affect people who experience limited exposure in a well-ventilated environment. Based on scientific facts, this is not true, especially in an indoor environment. </p><h3> Other trusted sources </h3><p><a class="break-all" href="https://www.unodc.org/documents/drug-prevention-and-treatment/cannabis_review.pdf " target="_blank" rel="noopener noreferrer">https://www.unodc.org/documents/drug-prevention-and-treatment/cannabis_review.pdf</a></p>',21),ne=i('<hr><section id="s-4"><h2 id="s-4t"> What is MMS? </h2><p> Miracle Mineral Solution, also Master Mineral Solution, or MMS, are the brand name for an aqueous solution of chlorine dioxide (ClO₂), an industrial bleach that was wrongly believed to treat diseases such as HIV, cancer and the common cold <sup><a href="https://en.wikipedia.org/w/index.php?title=Miracle_Mineral_Supplement&amp;oldid=1130854435" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="  Wikipedia contributors. (2022). Miracle Mineral Supplement. In Wikipedia, The Free Encyclopedia.">[37]</a></sup> <sup><a href="https://www.terviseamet.ee/et/uudised/mms-kloordioksiidil-pohinev-tervisele-kahjulik-lahus" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Estonian Drug Administration (Eesti Ravimiamet)(2018). MMS on kloordioksiidil põhinev tervisele kahjulik lahus.">[38]</a></sup>. Former Scientologist Jim Humble coined the name in his 2006 self-published book, The Miracle Mineral Solution of the 21st Century <sup><a href="https://uk.news.yahoo.com/parents-making-children-drink-bleach-160057178.html" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip=" Newsweek/Yahoo News. (January 28, 2018). Parents Are Making Their Children Drink Bleach to &#39;Cure&#39; Them of Autism.">[39]</a></sup>. Humble claims the chemical can cure HIV, malaria, hepatitis virus, H1N1 flu virus, common cold, autism, acne, cancer and other ailments. There are no clinical studies to verify these claims <sup><a href="https://www.terviseamet.ee/et/uudised/mms-kloordioksiidil-pohinev-tervisele-kahjulik-lahus" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Estonian Drug Administration (Eesti Ravimiamet). (July 20, 2018). MMS on kloordioksiidil põhinev tervisele kahjulik lahus.">[40]</a> <a href="https://www.fda.gov/consumers/consumer-updates/danger-dont-drink-miracle-mineral-solution-or-similar-products" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="U.S. Food and Drug Administration. (December 8, 2019). Danger: Don’t Drink Miracle Mineral Solution or Similar Products.">[41]</a></sup>, they come only from anecdotes and Humble&#39;s book <sup><a href="https://en.wikipedia.org/w/index.php?title=Miracle_Mineral_Supplement&amp;oldid=1130854435" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="  Wikipedia contributors. (2022). Miracle Mineral Supplement. In Wikipedia, The Free Encyclopedia.">[42]</a></sup>. Notwithstanding missing scientific proof, MMS has been promoted by different persons worldwide since then. </p><p> MMS is made by mixing an aqueous solution of sodium chlorite (NaClO₂) with an acid such as HCl, citrus juice or vinegar: </p><h4 class="mt-0" style="font-variant-numeric:lining-nums;"><span class="break-keep whitespace-nowrap">5NaCl0₂ + 4HCl</span> → <span class="break-keep whitespace-nowrap">5NaCl + 4ClO₂ + 2H₂O</span></h4><p> As a result, chlorine dioxide is produced, a toxic chemical that can cause nausea, vomiting, diarrhoea and life-threatening low blood pressure from dehydration <sup><a href="https://web.archive.org/web/20190814102219/https://www.fda.gov/news-events/press-announcements/fda-warns-consumers-about-dangerous-and-potentially-life-threating-side-effects-miracle-mineral" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Food and Drug Administration ( 2019). &#39;FDA warns consumers about the dangerous and potentially life threading side effects of Miracle Mineral Solution.&#39; fda.gov.">[43]</a></sup>. Sodium chlorite is the primary precursor of chlorine dioxide and is toxic even if ingested <sup><a href="https://web.archive.org/web/20070710214037/http://www.emea.europa.eu/pdfs/vet/mrls/sodiumchlorite.pdf" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="European Medicines Agency. (2007). Sodium Chlorite - Summary Report of the European Agency for the Evaluation of Medicinal Products - Veterinary Medicines Evaluation Unit (PDF).">[44]</a></sup>. High doses can cause acute renal failure. Low doses (approximately 1 gram) can cause nausea, vomiting, and intestinal inflammation, and even life-threatening in patients with glucose-6-phosphate dehydrogenase deficiency <sup><span class="tooltip" data-tip=" Lin J.L. &amp; Lim, P.S. (1993). Acute sodium chlorite poisoning associated with renal failure. Ren Fail. 15(5): 645–8. doi:10.3109/08860229309069417. PMID 8290712.">[45]</span></sup>. </p><p> Chlorine dioxide has also been used as a drinking water disinfectant <sup><span class="tooltip" data-tip="Block, Seymour Stanton (2001). Disinfection, Sterilization, and Preservation (5th ed.). Lippincott, Williams &amp; Wilkins. p. 215. ISBN 0-683-30740-1.">[46]</span></sup>. The European Commission directive <sup><a href="https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A31998L0083" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Council Directive 98/83/EC of 3 November 1998 on the quality of water intended for human consumption">[47]</a></sup> sets the maximum allowed concentration of chlorine dioxide in drinking water at no more than 0.2 parts per million (ppm), while the U.S. Environmental Protection Agency (EPA) has set it to 0.8 (ppm) <sup><a href="https://wwwn.cdc.gov/TSP/ToxFAQs/ToxFAQsDetails.aspx?faqid=581&amp;toxid=108" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Agency for Toxic Substances and Disease Registry - ToxFAQs™: Chlorine Dioxide &amp; Chlorite. www.atsdr.cdc.gov.">[48]</a></sup>. </p><h3 id="safety"> Safety </h3><p> The medical advice given is that anyone who has this product should stop using it immediately and throw it away. <sup><a href="https://www.terviseamet.ee/et/uudised/mms-kloordioksiidil-pohinev-tervisele-kahjulik-lahus" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Estonian Drug Administration (Eesti Ravimiamet). (July 20, 2018). MMS on kloordioksiidil põhinev tervisele kahjulik lahus. ">[49]</a> <a href="https://www.fda.gov/consumers/consumer-updates/danger-dont-drink-miracle-mineral-solution-or-similar-products" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="U.S. Food and Drug Administration. (December 8, 2019). Danger: Don’t Drink Miracle Mineral Solution or Similar Products.">[50]</a></sup> National agencies in many countries, <sup><a href="http://www.food.gov.uk/news-updates/news/2012/jul/cdswarning#.UJ8EzIawUzQ" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="UK Food Standards Agency. (July 3, 2012). Agency warning on chlorine solutions.">[51]</a> <a href="https://web.archive.org/web/20120520125838/http://food.gov.uk/news/newsarchive/2010/sep/mms" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip=" Food Standards Agency.(2012). Warning against consumption of Miracle Mineral Solution.">[52]</a> <a href="https://web.archive.org/web/20130606115516/http://moh.gov.ms/?p=803" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip=" Montserrat: Ministry of Health. (June 6, 2013)Product Warning: Miracle Mineral Solution.">[53]</a></sup> have warned of the effects of MMS: &quot;MMS is a 28% sodium chlorite solution which is equivalent to industrial-strength bleach. When taken as directed, it could cause severe nausea, vomiting and diarrhoea, potentially leading to dehydration and reduced blood pressure. If the solution is diluted less than instructed, it could cause damage to the gut and red blood cells, potentially resulting in respiratory failure.&quot; More dilute versions have the potential to do harm, although it is less likely. Sellers attribute vomiting, nausea, and diarrhoea to the effect of the product, but it is actually the product&#39;s toxicity <sup><a href="https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0648_summary.pdf" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="&#39;Chlorite (sodium salt) (CASRN 7758-19-2) | IRIS | US EPA&#39; (PDF). Epa.gov. United States Environmental Protection Agency.">[54]</a></sup>. </p><p> MMS is not approved for the treatment of any disease, and chronic exposure to small doses of chlorine dioxide could cause reproductive and neurodevelopmental damage. </p><h3 id="miracle-drug"> Marketing as a “miracle drug” </h3><p> According to marketers&#39; false claims, administering the miracle solution drops will quickly &quot;cure&quot; many or all diseases and ailments, including cancer, AIDS, influenza, autism, etc. In marketing, the primary method is network marketing and communities close to the public in social networks. Consumer-oriented communication includes the terminology of healthy lifestyles (&quot;eco&quot; and the like), exploits the lack of awareness and desperation of sensitive consumers, and often also the aversion to conventional medicine <sup><a href="https://et.wikipedia.org/wiki/MMS" target="_blank" rel="noopener noreferrer">[55]</a></sup>. </p><h3 id="myth-9"><span class="text-rose-400">Myth No 9:</span> MMS cures COVID-19 </h3><p> Though there is no scientific basis for the claim that MMS can cure COVID-19 or any other disease, <sup><a href="https://www.mysuncoast.com/2020/07/08/federal-agencies-hazmat-crews-respond-bradenton-church-selling-covid-miracle-solution/" target="_blank" rel="noopener noreferrer">[56]</a><a href="https://www.thedailybeast.com/qanon-conspiracy-theorists-magic-cure-for-coronavirus-is-drinking-lethal-bleach" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Sommer, Will (28 January 2020). &#39;QAnon-ers&#39; Magic Cure for Coronavirus: Just Drink Bleach!&#39;. Daily Beast. Archived from the original on 10 February 2020.">[57]</a><a href="https://www.youtube.com/watch?v=QEZpb4an8eM" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Halperin, Dan (30 January 2020). &#39;QAnon YouTubers Are Telling People to Drink Bleach to Ward Off Coronavirus&#39;. Youtube. Rolling Stone.">[58]</a></sup> during the COVID-19 pandemic, many earlier supporters of MMS of other illnesses, such as QAnon supporter Jordan Sather and the Genesis II Church of Health and Healing in the U.S., began touting it as a cure for COVID-19. E.g. Earlier in the summer of 2019, the Genesis II Church of Health and Healing held seminars to promote MMS in Chile, Ecuador, South Africa and New Zealand <sup><a href="https://www.theguardian.com/us-news/2019/aug/16/bleach-based-miracle-cure-group-seminar-new-york" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Pilkington, Ed (2019-08-16). &#39;Group to tout bleach-based &#39;miracle cure&#39; at upstate New York &#39;seminar&#39;&#39;. The Guardian. Retrieved 2019-08-16.">[59]</a></sup>. In 2020, the U.S. Attorney’s Office for the Southern District of Florida received an injunction against another church branch that specifically marketed MMS as a COVID-19 treatment using anonymous testimony and citing conspiracy theories <sup><a href="https://www.cbsnews.com/news/florida-church-coronavirus-bleaching-agent-cure-covid-19/" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Quinn, Melissa; Legare, Legare; Hymes, Clare (April 17, 2020), &#39;Feds go after self-described church in Florida selling bleaching agent as cure for COVID-19&#39;, CBS News.">[60]</a></sup>. The court issued orders to shut down all websites selling MMS, to prevent the church from creating new websites, and to confiscate all materials used to make MMS. The church was also instructed to notify customers that the product distribution had been illegal <sup><a href="http://www.ethicalagents.co.nz/ProductPDF/Tristel-Trio-Wipe-System.pdf" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="&#39;Tristel Wipes System Product Information&#39; (PDF). Ethical Agents. Archived from the original (PDF) on April 15, 2016.">[61]</a></sup>. </p><p> In Bolivia, officials in Cochabamba promoted MMS as a cure for COVID-19, and Congress passed a bill to authorise the “manufacture, marketing, supply and use of chlorine dioxide solution for the prevention and treatment of coronavirus”. At least 15 people were poisoned as a result <sup><a href="https://www.theguardian.com/world/2020/jul/17/bolivia-coronavirus-toxic-bleach-chlorine-dioxide" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="Cochabamba, Associated Press in (17 July 2020). &#39;Desperate Bolivians seek out toxic bleach falsely touted as Covid-19 cure&#39;. The Guardian. Retrieved 2 February 2021.">[62]</a></sup>. </p><h3 id="myth-10"><span class="text-rose-400">Myth No 10:</span> MMS cures autism </h3><p> ABC News and KABC-TV in the U.S. investigated the MMS phenomenon in 2016 and uncovered an &quot;underground network&quot; centred around southern California promoting MMS as a cure for conditions including cancer, Parkinson&#39;s disease and childhood autism <sup><a href="https://uk.news.yahoo.com/parents-making-children-drink-bleach-160057178.html" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="&#39;Parents Are Making Their Children Drink Bleach to &#39;Cure&#39; Them of Autism&#39;. Newsweek/Yahoo News. 28 January 2018.">[63]</a></sup>. </p><p> So did, e.g. Kerri Rivera (U.S.), who advocated for, and gave parents unsubstantiated and unprofessional medical and health advice for using MMS to “cure” autism and other serious illnesses. Later on, she was criminally charged. However, Rivera operated a Facebook page and the website that promoted dangerous MMS enemas as an autism treatment, and claimed that the intestinal lining children expel as a result is parasites (“rope worms”) <sup><a href="https://en.wikipedia.org/wiki/Intestinal_epithelium" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="&#39;Rope worms&#39; (or &#39;ropeworms&#39;) is a pseudoscientific term for long thin pieces of damaged intestinal epithelium or other bowel content that have been misidentified as human parasitic worms.">[64]</a></sup>, which was patently false <sup><a href="https://www.autism.com/statement_mms" target="_blank" rel="noopener noreferrer" class="tooltip" data-tip="&#39;Warning Against Chlorine Dioxide Use&#39;. Autism Research Institute. Retrieved 24 September 2016.">[65]</a></sup>. </p><h3> More sources about MMS consumption as a medicine: </h3><p> Parikh, M., Redfield, R., Wang, C., &amp; Lautenslager, T. (2021). Miracle Mineral Solution: In No Way a “Miracle”. <i>Official journal of the American College of Gastroenterology</i>, 116, 832-833. </p></section>',2);function te(c,u){const l=h,d=k,o=g,n=v;return r(),p("div",Ra,[e(d,null,{default:t(()=>[e(l,{class:"w-full lg:max-w-xs print:hidden",key:"drugs-bg-en"})]),_:1}),a("section",Wa,[e(o,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),Ua,a("section",$a,[za,La,e(n,{src:"https://evidence.onkel.ee/assets/drugs__cannabis.webp",credits:"Pixabay: https://pixabay.com/photos/marijuana-herbal-cannabis-hemp-5858148/",elevated:!0},{caption:t(()=>[Ga,s(" Cannabis plants ")]),_:1}),Qa,Ya]),a("section",Xa,[Za,e(n,{elevated:"",src:"https://evidence.onkel.ee/assets/drugs__cannabis-medical-effects.webp"},{caption:t(()=>[ae,s(" Cannabis health effects. ")]),_:1}),ee,e(n,{elevated:"",src:"https://evidence.onkel.ee/assets/drugs__cannabis-products.webp"},{caption:t(()=>[se,s(" Cannabis and products containing certain concentrations of cannabinoids. ")]),_:1}),ie]),ne])])}const oe=f(Va,[["render",te]]),he={__name:"background",setup(c){const{locale:u}=M();return(l,d)=>{const o=F,n=oa,y=_a,w=Fa,j=oe;return r(),p("div",null,[b(u)==="et"?(r(),m(o,{key:0})):b(u)==="el"?(r(),m(n,{key:1})):b(u)==="pt"?(r(),m(y,{key:2})):b(u)==="sv"?(r(),m(w,{key:3})):(r(),m(j,{key:4}))])}}};export{he as default};
